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The human body is continuously facing a high load of microbes which 
can be beneficial, harmless or pathogenic to the host. The human body 
is armed with defense mechanisms that combat microbial attack and 
the entry of microbes is detected by cells of the innate immune system. 
Dendritic cells and macrophages are central innate effector cells 
that detect conserved microbial patterns via various receptors. This 
ultimately leads to the activation of intracellular signaling cascades 
and the induction of host genes such as cytokines involved in defense 
mechanisms against microbes.
In this study, we examined the activation of innate immune responses 
in response to non-pathogenic and pathogenic bacteria including 
strains belonging to Lactobacillus, Bifidobacterium and Streptococcus 
species. The results show that microbe-stimulated dendritic cells and 
macrophages differentially produce cytokines in response to various 
bacterial strains which may modulate the formation of adaptive 
immune responses. This study reveals new information on how our 
immune system responds to non-pathogenic and pathogenic microbes.
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Abstract 
Sinikka Latvala, Activation of Innate Immune Responses by Non-pathogenic and 
Pathogenic Bacteria in Human Leukocytes. National Institute for Health and 
Welfare (THL), Research 138. ?? pages. Helsinki, Finland 2014. ISBN 978-952-
302-312-3 (printed); ISBN 978-952-302-313-0 (online publication) 
 
The human body is continuously interacting with microbes. Cells of the immune 
system protect the host from microbes some of which can occasionally cause 
diseases. Macrophages and dendritic cells (DC) play a central role in innate and 
adaptive immune responses and they are activated in response to microbial 
stimulation. Macrophages function mainly locally in peripheral tissues taking up and 
destroying microbial pathogens. They are also important in maintaining 
inflammatory responses in inflamed tissues. DCs take up microbes which triggers 
DC maturation and migration of the cells into local lymph nodes, where antigen 
presentation to naïve T cells and induction of adaptive immune responses takes 
place. During activation these cells produce cytokines, soluble mediators that 
regulate host immune responses. Recognition of microbes is regulated by multiple 
host cell surface and intracellular receptor systems which after recognition of 
microbes or their structural and genetic components activate intracellular signalling 
pathways ultimately leading to the expression of genes involved in immune 
responses. 
 
In this thesis the interactions between human leukocytes and various bacteria were 
studied using human primary macrophages and DCs. The innate immune responses 
induced by probiotic and other non-pathogenic Gram-positive bacteria, some of 
which are part of the normal gastrointestinal microbiota, were compared with the 
responses induced by a pathogenic bacterium Streptococcus pyogenes (group A 
streptococcus, GAS). The differences in the gene expression profiles of cytokine and 
chemokine genes and the activation of different signalling pathways were analysed. 
Also the anti-inflammatory potential of different bacteria was evaluated to predict 
their immunomodulatory capacity for potential clinical use. 
 
Macrophages and DCs were compared in their cytokine responses to different non-
pathogenic bacteria. Although both cell types effectively destroy invading microbes 
the cytokine patterns produced by the two cell types in response to bacterial 
stimulation varied significantly. Macrophages responded to bacterial stimulation in a 
nearly similar fashion whether the bacteria had probiotic, non-pathogenic, or 
pathogenic characteristics. Interestingly, DCs showed a much wider variability in 
their responses to different bacteria. Some non-pathogenic bacteria did not induce 
detectable levels of cytokines in DCs while others were even more efficient than S. 
pyogenes in inducing cytokine responses. DC maturation marker molecules were 
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induced in response to interaction with non-pathogenic bacteria with relatively weak 
cytokine production patterns. This led to a semi-mature DC phenotype, which could 
be involved in tolerogenic responses seen in host cell interactions with commensal 
bacteria. 
 
The other focus of this work was to evaluate the role of dynamin-dependent 
endocytosis and streptococcal virulence factors, streptolysins, in the immune 
responses induced by S. pyogenes in macrophages. Streptolysins were not critical for 
the inflammatory responses induced by this bacterium, suggesting a cooperation of 
various virulence factors in bacterial pathogenesis. 
 
Taken together, this work provides better understanding of the functions of the 
innate immune system upon contact with non-pathogenic and pathogenic bacteria. 
The results may provide useful information for the interpretation of the results 
obtained from probiotic clinical trials and help to select new candidate probiotic 
strains for clinical use. In addition, this work identifies new details on the 
mechanisms of S. pyogenes -induced inflammatory responses. 
 
Keywords: cytokine, dendritic cell, macrophage, innate immunity, bacterium 
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Tiivistelmä 
Sinikka Latvala, Innate Immune Responses Induced by Non-pathogenic and 
Pathogenic Bacteria in Human Leukocytes [Ei-patogeenisten ja patogeenisten 
bakteerien aiheuttama luontaisen immuniteetin aktivoituminen ihmisen 
leukosyyteissä]. Terveyden ja hyvinvoinnin laitos. Tutkimus 138. ?? sivua. 
Helsinki, Finland 2014. ISBN 978-952-302-312-3 (painettu); ISBN 978-952-302-
313-0 (verkkojulkaisu) 
 
Elimistön solut, erityisesti epiteelisolut ja immuunijärjestelmän solut, sekä 
epiteelipinnoilla elävät bakteerit ovat jatkuvasti vuorovaikutuksessa toistensa 
kanssa. Osa mikrobeista on harmittomia, jopa hyödyllisiä, toiset puolestaan voivat 
aiheuttaa tauteja päästessään elimistöön. Ihmisen immuunipuolustus voidaan jakaa 
luontaiseen ja hankittuun immuniteettiin. Luontainen immuniteetti pyrkii tuhoamaan 
elimistölle vaaralliset mikrobit nopeasti syöjäsolujen kuten makrofagien ja 
antigeeneja esittelevien dendriittisolujen toimesta. Nämä solut tunnistavat 
bakteereita erilaisten hahmontunnistusreseptoreiden välityksellä ja tuottavat 
runsaasti sytokiineja, jotka toimivat välittäjämolekyyleinä ohjaten sekä luontaista 
että hankittua immuunivastetta. Tuotetut sytokiinit riippuvat kohdatun mikrobin tai 
antigeenin ominaisuuksista sekä niihin reagoivasta solutyypistä. Sytokiinituotanto 
on tarkkaan säädeltyä ja mikrobin tai antigeenin virheellinen tunnistus voi johtaa 
joko immuunivasteen tehottomaan tai liian voimakkaaseen aktivoitumiseen. 
 
Tässä työssä on tutkittu ihmisen leukosyyttien ja grampositiivisten bakteerien välisiä 
vuorovaikutussuhteita käyttäen mallina terveen ihmisen veren monosyyteistä 
erilaistettuja dendriittisoluja ja makrofageja. Työssä on havaittu selviä eroja 
probioottien, potentiaalisten probioottien ja patogeenisen Streptococcus 
pyogenes -bakteerin kyvyssä aktivoida immuunivasteita. Myös bakteerien anti-
inflammatorinen potentiaali määritettiin niiden mahdollisten kliinisten vaikutusten 
ennustamiseksi. 
 
Bakteereilla stimuloitujen dendriittisolujen kypsymistä, aktivaatiota ja 
sytokiinituotantoa verrattiin makrofageissa syntyviin vasteisiin. Pyrkimyksenä oli 
havaita mahdollisia eroja bakteerien kyvyssä aktivoida ihmisen 
immuunijärjestelmän soluja. Ei-patogeeniset bakteerit saivat aikaan dendriittisolujen 
kypsymisen ja kostimulatoristen molekyylien ilmentymisen solujen pinnalla, mutta 
niiden kyky aktivoida sytokiinituotanto vaihteli huomattavasti. Osa bakteereista ei 
aktivoinut sytokiinituotantoa lainkaan, toiset puolestaan aktivoivat sen 
voimakkaammin kuin patogeeninen S. pyogenes -bakteeri. Jotkut tutkituista 
bakteereista saivat aikaan dendriittisolujen osittaisen kypsymisen. Tällaiset solut 
ilmentävät kostimulatorisia molekyylejä, mutta eivät tuota sytokiineja, ja niiden 
uskotaan osallistuvan tolerogeenisten vasteiden syntymiseen. Tämä saattaa selittää 
Activation of Innate Immune 
Responses by Non-pathogenic 
and Pathogenic Bacteria in 
Human Leukocytes 
 
 
THL — Research 138 • 2014 8 
 
elimistön ja normaalin mikrobiston välistä toleranssia. Makrofageissa puolestaan 
kaikki tutkitut bakteerit saivat aikaan voimakkaan tai suhteellisen voimakkaan 
inflammatorisen vasteen. Tämä viittaa siihen, että bakteerin 
taudinaiheuttamiskyvyllä ei ehkä ole niin suurta merkitystä makrofageissa syntyvän 
luontaisen immuunivasteen kannalta. 
 
Tutkimuksessa selvitettiin myös dynamiinivälitteisen endosytoosin osuutta 
puolustusvasteen synnyssä sekä verrattiin villityyppisen S. pyogenes –bakteerin ja 
streptolysiinivirulenssitekijöiden osalta puutteellisten bakteerien kykyä aktivoida 
makrofageja. Tutkimuksessa havaittiin, että streptolysiinit eivät ole välttämättömiä 
S. pyogenes -bakteerin aikaansaamien inflammatoristen vasteiden synnyssä. 
 
Väitöskirjatyöstä saatu tieto auttaa ymmärtämään luontaisen immuunijärjestelmän 
toimintaa elimistön kohdatessa erilaisia bakteereita. Saatua tietoa voidaan käyttää 
hyödyksi tutkittaessa probioottisten bakteerien aikaansaamia terveysvaikutuksia ja 
niiden taustalla olevia mekanismeja sekä valittaessa mahdollisia uusia bakteereita 
kliinisiin kokeisiin. Lisäksi tutkimus osaltaan paljastaa S. pyogenes -infektioiden 
taustalla olevia immunologisia mekanismeja, joita voidaan hyödyntää kehitettäessä 
menetelmiä hallita bakteerin aiheuttamia voimakkaita immuunivasteita. 
 
Avainsanat: sytokiini, dendriittisolu, makrofagi, luontainen immuunijärjestelmä, 
bakteeri 
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Sammandrag 
Sinikka Latvala. Activation of Innate Immune Responses by Non-pathogenic and 
Pathogenic Bacteria in Human Leukocytes [Aktivering av leukocyter i det naturliga 
immunförsvaret orsakad av icke-pathogena och pathogena bacterier] Institutet för 
hälsa och välfärd (THL), Forskning 138. ?? sidor. Helsinki, Finland 2014. ISBN 
978-952-302-312-3 (tryckt); ISBN 978-952-302-313-0 (nätpublikation) 
 
Människans immunförsvar och epitelceller är i ständig växelverkan med mikrober. 
En del av mikroberna är oförargliga, eller till och med nyttiga, medan andra kan 
orsaka sjukdom. Immunförsvaret kan delas in i det naturliga och det adaptiva 
immunförsvaret. Det naturliga immunförsvaret bekämpar skadliga mikrober med 
hjälp av ätarceller som t.ex. makrofager och antigenpresenterande dendritceller. Med 
hjälp av olika receptorer känner de här cellerna igen ytstrukturer hos 
sjukdomsalstrande bakterier och producerar rikligt med cytokiner. Typen av 
cytokiner beror på mikroben eller antigenen som utlöser produktionen samt vilken 
av kroppens celler mikroben eller antigenen kommer i kontakt med. 
Cytokinproduktionen är starkt reglerad och felaktig identifiering av mikrober eller 
antigener kan leda till ett för svagt eller å andra sidan ett för kraftigt immunsvar. 
 
I den här avhandlingen granskades växelverkan mellan människans leukocyter och 
grampositiva bakterier genom att använda dendritceller och makrofager som 
differentierats från monocyter isolerade från friska blodgivare. Resultaten visar att 
det finns klara skillnader mellan hur probioter, potentiella probioter och patogena 
Streptococcus pyogenes -bakterier aktiverar immunsvaret. Vidare bestämdes 
bakteriernas anti-inflammatoriska potential som kan ha betydelse för deras kliniska 
verkan. 
 
Dendritceller som stimulerats med bakterier studerades och cellernas utveckling, 
aktivering och cytokinproduktion jämfördes med det immunsvar som makrofagerna 
producerade. Syftet var att undersöka om det finns skillnader mellan hur olika 
bakterier aktiverar cellerna i människans immunförsvar. De icke-patogena 
bakterierna fick dendritcellerna att mogna och uttrycka co-stimulatoriska molekyler 
på sin yta men bakteriernas förmåga att aktivera cytokinproduktionen varierade 
markant. En del av bakterierna aktiverade inte cytokinproduktionen alls medan 
andra orsakade kraftigare cytokinproduktion än sjukdomsalstraren Streptococcus 
pyogenes. Delvis mogna dendritceller som uttycker co-stimulatoriska molekyler på 
sin yta men inte producerar cytokiner fungerar sannolikt som en del av det 
tolerogena immunsvaret och främjar kroppens tolerans för normalflorans mikrober. 
Alla undersökta bakterier orsakade å andra sidan ett kraftigt eller relativt kraftigt 
inflammatoriskt svar hos makrofager, vilket tyder på att bakteriens förmåga att 
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orsaka sjukdom kanske inte har så stor betydelse för det naturliga immunsvar som 
makrofagerna utvecklar. 
 
I undersökningen användes olika varianter av S. pyogenes: en bakteriestam av 
vildtyp och två bakteriestammar som vardera saknade någon av streptolysin-
virulensfaktorerna. När dessa bakteriestammars förmåga att aktivera vita blodceller 
jämfördes visade resultaten att streptolysinerna inte är nödvändiga för att ge upphov 
till ett inflammatoriskt svar. Vidare undersöktes den dynaminmedierade 
endocytosens roll i aktiveringen av immunsvaret. 
 
Resultaten från den här undersökningen hjälper oss att förstå hur det naturliga 
immunförsvaret fungerar i växelverkan med olika bakterier. Kunskapen kan 
utnyttjas för att undersöka de hälsoeffekter som probiotiska bakterier ger upphov till 
och kan hjälpa till att identifiera nya potentiellt gynnsamma bakteriearter för 
kliniska försök. Resultaten avslöjar också nya detaljer om de immunologiska 
mekanismer som ligger bakom infektioner orsakade av S. pyogenes. Dessa kan 
utnyttjas för att utveckla metoder som hjälper till att dämpa det kraftiga 
inflammationssvar som orsakas av bakterien. 
 
 
Nyckelord: cytokin, dendritcell, makrofag, det naturliga immunförsvaret, bakterie 
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1 Introduction 
The human body is continuously exposed to a variety of microorganisms most of 
which are beneficial or harmless to the host. Mechanical and chemical barriers that 
separate the external environment from the internal sterile milieu protect the host 
from pathogenic microorganisms that occasionally cause severe infections. 
Mechanical barriers such as the epidermis and mucosa that line the internal body 
cavities effectively prevent pathogen entry when intact. Additionally, chemical 
barriers such as low pH and secreted antimicrobial compounds make the milieu 
unfavorable for bacterial growth. Sometimes these barriers are breached by an injury 
or via animal vectors allowing pathogenic bacteria to cross the epithelium, 
sometimes leading to an infectious disease. During the course of evolution, non-
pathogenic bacteria of the normal microbiota have developed commensal and 
mutually beneficial relationships with their hosts, and pathogenic bacteria have 
evolved several strategies to enter the host and avoid host immune responses. 
 
The intestine is a potential entry route for a number of pathogenic bacteria. The 
integrity of the epithelial barrier in the intestine can be improved by bacteria with 
health promoting properties termed probiotics. They act through diverse 
mechanisms to maintain intestinal homeostasis and prevent pathogen growth and 
attachment to the mucosal and epithelial surfaces. In addition, the ability of probiotic 
bacteria to modulate the intestinal immune responses has been demonstrated. 
 
The cellular components of the immune system that detect and eliminate the 
invaders are divided into two arms; innate and adaptive responses. Innate immunity 
represents the front line of immune responses against invading pathogens. It 
provides unspecific recognition of microorganisms by complement, destruction of 
infected cells by natural killer (NK) cells, and rapid activation of phagocytic cells 
including macrophages, dendritic cells (DC), and neutrophils that detect, ingest, and 
destroy foreign material. Innate immunity also includes soluble molecules that 
enhance antimicrobial resistance or are directly involved in bacterial destruction 
such as defensins. Cells of the innate immune system are scattered throughout the 
body to act as sentinels of danger signals. Recognition of microbes is based on the 
germ-line encoded pattern recognition receptors (PRRs) that sense conserved 
microbial structures absent from the host. In response to microbial stimuli, these 
cells secrete soluble mediators such as cytokines and chemokines to initiate 
appropriate immune responses. 
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When the innate immune system is unable to clear the infection, the adaptive arm of 
the immune system is activated. It complements the innate immune system and is 
responsible for the elimination of pathogens at later phase of infection. DCs act in 
the interface of innate and adaptive immune system to activate T and B cell 
functions. This highly specific part of the immune system acts through clonally 
selected receptors. Adaptive immunity is activated slowly, in days or weeks, and it is 
responsible for the immunological memory and protective immunity. Upon 
reinfection, the immunological memory offers rapid and efficient responses against 
pathogens. Adaptive immunity also contributes to the development of autoimmune 
diseases, allergy, and allograft rejection. 
 
Innate and adaptive parts of the immune system communicate through cytokines, 
produced by antigen presenting cells (APCs), macrophages and DCs. Secretion of 
cytokines in response to microbial stimulation must be tightly regulated to avoid 
tissue destruction and detrimental effects on the host. On the other hand, the ability 
of non-pathogenic and probiotic bacteria to induce host cell cytokine production, 
might have beneficial immunomodulatory effects. The ability of non-pathogenic 
bacteria to fine tune the inflammatory responses offers an intriguing field for 
research with a great potential to modulate host immune responses. 
 
In the present work the cytokine profiles induced by non-pathogenic bacteria and 
their abilities to activate DC maturation were analysed and compared with the 
reponses induced by a pathogenic bacterium Streptococcus pyogenes (group A 
streptococcus, GAS). The immune responses of multiple bacterial strains were 
compared in human monocyte-derived (mo)DC and macrophage cell models. 
Moreover, we addressed the question, how non-pathogenic bacteria-induced 
responses are regulated and what are the key molecules controlling these actions. In 
addition to non-pathogenic bacteria-induced responses, the role of bacterial 
virulence factors called streptolysins of pathogenic GAS and the role of dynamin-
dependent endocytosis in GAS-induced inflammatory responses were analysed in 
the macrophage model to obtain better understanding of their importance and 
contribution to GAS infections. 
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2 Review of the literature 
2.1 Phagocytic cells of the immune system 
 
One of the mechanisms to control pathogenic invasion is the ability of immune cells 
to internalize microbes from their milieu in a process called phagocytosis. 
Professional phagocytes such as neutrophils, macrophages, and DCs utilize 
phagocytic receptors to take up also other foreign particles and apoptotic cells. DCs 
and macrophages are distinguished from other phagocytes by their ability to act as 
APCs and to initiate adaptive immune responses via T and B cell activation (Figure 
1). 
 
2.1.1 Macrophages 
 
Macrophages are derived from myeloid progenitor cells in the bone marrow. These 
precursor cells develop into monocytes and circulate in blood before homing into 
different tissues where they give rise to a variety of tissue resident macrophages or 
specialized cells such as dendritic cells [1-3]. Macrophages are found throughout the 
body and they show great functional diversity by participating in different 
physiological and pathological processes including development, bone remodeling, 
wound healing, and removal of apoptotic cells [4]. Macrophages are involved in the 
elimination of pathogens by detecting, ingesting, and destroying them and they can 
also act as APCs to initiate adaptive immune responses. Tissue macrophages are 
replaced by newly recruited blood monocytes as they undergo programmed cell 
death within weeks or months [5]. However, also local proliferation of tissue 
macrophages has been suggested [6]. 
 
The basal activity as well as the ability of macrophages to respond to inflammatory 
stimuli varies considerably depending on their location and cytokine milieu of their 
microenvironment [3, 4, 7]. Macrophage activation and differentiation are also 
dependent on their cell surface receptors or intracellular molecules, which mediate 
phagocytosis and activation of signalling cascades, respectively. These receptors 
include complement, scavenger, and Fc-receptors as well as lectin receptors, cluster 
of differentiation (CD) 14, and Toll-like receptors (TLRs) [4, 8]. 
 
Homeostatic processes are mediated independently of immune cell signalling, but in 
response to inflammatory stimuli macrophages activate multiple signalling pathways 
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resulting in the production of various inflammatory mediators including cytokines 
and chemokines. The differentiation lineage of macrophages depends on the signals 
they receive from the environment. The microbicidal activity of macrophages is 
enhanced by cytokines, including interferon (IFN)-γ, produced by other immune 
cells such as NK and T cells. Instead, regulatory macrophages are generated in 
response to various stimuli including immune complexes, prostaglandins, and 
interleukin (IL)-10. These regulatory cells suppress immune responses via increased 
IL-10 production. In addition, the cytokines produced by macrophages can influence 
their own activation in an autocrine fashion [3, 4]. Since excessive cytokine 
production can lead to tissue damage of the host, the activation of macrophages must 
be tightly controlled. Nevertheless, macrophages are shown to contribute to the 
development of allergy and hypersensitivity and they play a pathogenic role in 
several autoimmune diseases [3, 4]. 
 
Macrophages differ morphologically and phenotypically in different tissues. The 
largest reservoir of macrophages resides in the gastrointestinal mucosa, which is the 
largest body surface to interact with the external environment [5]. The first cells to 
contact microbes after the epithelial barrier are APCs and intraepithelial 
lymphocytes. Intestinal macrophages have a unique phenotype characterized by 
strong phagocytic and bactericidal activity with downregulated proinflammatory 
functions. They are recruited to lamina propria by endogenous chemoattractants in 
the non-inflamed mucosa and by bacterial products and inflammatory chemokines 
during inflammation. Interestingly, resident intestinal macrophages do not mediate 
mucosal inflammation, since their proinflammatory cytokine production is 
downregulated, regardless of whether the stimulus is a soluble factor or a phagocytic 
event [9, 10]. It is believed that the newly recruited blood monocytes are involved in 
the inflammatory reactions in the gut [5]. 
 
Some pathogenic bacteria such as Listeria, Salmonella, Shigella, and Legionella 
have evolved strategies to survive inside macrophages by interfering with the 
molecules regulating their recognition or destruction by phagocytes [11-13]. 
 
2.1.2 Dendritic cells 
 
DCs are the most potent APCs that initiate and control the quality of adaptive 
immune responses (Figure 1). DCs reside in an immature state in peripheral tissues 
near potential pathogen entry sites such as the skin, mucosal surfaces, and lymphoid 
organs. As immature DCs they continuously monitor their milieu in the tissues and 
take up particles and soluble components. DCs are involved in bacterial recognition, 
induction of tolerance, and shaping of T cell-mediated responses. DCs are able to 
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present their antigens to naïve T cells, whereas macrophages only activate primed T 
cells [14]. 
 
DCs can arise from myeloid or lymphoid progenitors. DC subsets representing the 
myeloid DC (mDC) lineage can be found in peripheral tissues, secondary lymphoid 
organs, and in blood. Another DC subset, plasmacytoid DCs (pDC) of lymphoid 
origin, circulate in blood [15]. DC subsets can be classified based on their surface 
molecules of myeloid or lymphoid lineage or their location as they express different 
TLRs and produce a distinct sets of cytokines in response to microbial stimulation 
[15, 16]. 
 
Upon encountering an antigen, DCs undergo a maturation process including 
morphological changes, reduction in endocytic capacity, and secretion of cytokines 
and chemokines. Maturation also includes increased expression of major 
histocompatibility complex (MHC) molecules and costimulatory molecules such as 
CD80 and CD86 required for T cell activation. During maturation DCs migrate into 
the peripheral lymph nodes to present peptides from ingested antigens to T and B 
cells to initiate adaptive immune responses [14]. The outcome of the immune 
response is influenced by the extracellular environment, nature of the signal, and the 
type of DCs responding to it [17]. 
 
Depending on the stimulus, DCs produce different cytokines to induce T cell 
polarization. IL-12 family cytokines support Th1 polarization which is important in 
protection against intracellular pathogens and Th2 polarization induced by IL-4 is 
important against extracellular and parasitic pathogens. While IL-10 favors the 
generation of Treg cells that suppress inflammatory reactions and are critical in 
maintaining tolerance, IL-1β and IL-23 support Th17 differentiation which is involved 
for example in intestinal immune responses and in autoimmune inflammation [18-20]. 
However, DCs show considerable plasticity in their functions and can change their 
polarization in response to alterations in their local cytokine milieu [21]. 
 
DCs have been shown to participate in unwanted and uncontrolled immune 
responses including allergy, autoimmunity, cancer, and transplant rejection [15, 22]. 
Furthermore, DCs are targets for microbes that have evolved strategies for 
disturbing DC functions and their recognition and degradation by immune cells. 
Microbes can induce apoptosis and interfere with DC maturation and migration to 
prevent the initiation of protective immune responses. Some pathogenic bacteria use 
DC receptors to enter the cells and modulate the cytokine profiles produced by the 
cells in favour for bacterial survival [15, 23]. 
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In the gastrointestinal tract DCs are an important cell type responding to microbial 
entry into the underlying tissues. The recognition of bacteria as either commensal or 
pathogenic and whether to activate an inflammatory, tolerizing, or no response is an 
important challenge to the mucosal immune system. It has been reported that DCs 
residing under the epithelial cells in lamina propria, can reach their dendrites 
through the tight junctions of epithelial cells into the gut lumen and sample for 
antigens or microbes [24, 25]. 
 
A challenge in human DC studies has been the low number of mDCs and pDCs in 
human blood. Most of the in vitro studies utilizing human DCs have been conducted 
with monocytes that are differentiated into DCs in the presence of IL-4 and 
granulocyte-macrophage colony stimulating factor (GM-CSF) [26]. These cells are 
called monocyte-derived DCs (moDCs) and they closely resemble blood-derived 
mDCs [27, 28]. 
 
 
 
 
Figure 1.  Schematic representation of the interplay between the cellular innate 
and adaptive immune responses. Interactions between macrophages, 
DCs, and CD4+ T cells are shown. 
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2.2 Microbe recognition 
 
Rapid recognition of pathogens and other danger signals is necessary for the 
activation of immune responses. Cells of the innate immune system, including 
macrophages and DCs recognize conserved microbe-associated molecular patterns 
(MAMPs) and intracellular danger signals through different kinds of receptors 
(Table 1). These receptors include TLRs, nucleotide-binding and leucine-rich repeat 
containing gene family receptors (NLRs), and retinoic acid-inducible gene I (RIG-
I)-like receptors (RLRs) which are able to activate intracellular signalling pathways 
resulting in the expression of genes that contribute to the magnitude and quality of 
immune responses. 
 
2.2.1 Toll-like receptors (TLRs) 
 
TLRs are critical components of the innate immune system recognizing both 
microbe-specific molecules and damaged host cell components [29-31]. The Toll 
protein was initially discovered in Drosophila [32]. Currently, 13 members of the 
TLR family have been identified in mammals, of which 10 are found in humans. 
These type I transmembrane glycoproteins consist of a leucine-rich repeat (LRR) 
domain responsible for ligand recognition and receptor dimerization, and a 
cytoplasmic Toll/IL-1 receptor (TIR) domain that controls signalling. Ligand 
engagement by TLR leads to receptor dimerization and activation of intracellular 
signalling pathways including adaptor molecules, kinases, and transcription factors 
ultimately leading to the transcription of the genes responsible for immune 
responses [33, 34]. The most important cell types that express TLRs are 
macrophages, DCs, and B lymphocytes. Also other cell types express these receptors 
constitutively or upon microbial stimulation [35, 36]. 
 
TLRs can be located on the cell surface (TLRs 1, 2, 4, 5, 6, and 10) or in 
intracellular compartments such as endosomes and lysosomes (TLRs 3, 7, 8, 9) 
(Figure 2). For most TLRs ligand specificity has been identified. TLR2 associates 
with TLR1 or TLR6 to recognize Gram-positive bacterial cell wall components 
including lipoproteins, lipoteichoic acids (LTA), and peptidoglycan (PG). TLR4 and 
TLR5 in turn recognize lipopolysaccharide (LPS) from Gram-negative bacteria and 
the structural epitope of bacterial flagellin, respectively. TLRs 3, 7, 8, and 9 respond 
to microbe-derived nucleic acids, such as single-stranded or double-stranded RNA 
and DNA or unmethylated CpG motifs of bacterial DNA [34]. Localization and 
ligand for TLR10 are still unclear, however, bacterial, viral, and fungal ligands and 
association with TLR2 on the cell surface have been suggested [37, 38]. The TLR 
system is very complex since one microbe can activate several TLRs via different 
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MAMPs to trigger multiple downstream signalling pathways for rapid inflammatory 
responses. The expression levels of TLRs and the distribution of these receptors on 
different cell types reflects their ability to respond to specific stimuli. This 
determines in part the characteristic patterns of cytokines, chemokines, and 
interferons that are induced by different microbes in various cell types. 
 
Traditionally, Gram-positive bacteria are considered to be recognized by TLR2, one 
of the most extensively studied receptors in innate immunity. Heterodimerization of 
TLR2 with TLR1 or TLR6, and possibly with TLR10, gives the receptor the ability 
to recognize ligands with diverse structures such as LTA, lipoproteins, PG, porins, 
and virus capsids [39, 40]. Both TLR2/TLR1 and TLR2/TLR6 receptor dimers 
activate the same signalling cascade, resulting in the activation of identical genes 
[41]. TLR2 heterodimers are known to associate with co-receptors and accessory 
molecules such as CD36 [42], CD14 [43, 44], and Dectin-1 [45] to expand the 
ligand repertoire. 
 
2.2.2 Activation of signalling pathways via TLRs 
 
A number of different signalling pathways are activated in response to ligand 
recognition by TLRs. The cytoplasmic TIR domains of TLRs are responsible for 
downstream signalling. These domains recruit TIR domain containing adaptor 
molecules, including myeloid differentiation primary response gene 88 (MyD88) 
protein, TIR domain containing adaptor protein (TIRAP), TIR domain containing 
adaptor inducing IFN-β (TRIF), TRIF related adaptor molecule (TRAM), and sterile 
alpha and HEAT-Armadillo motifs (SARM) to transmit downstream signalling. 
Three major signalling pathways mediate TLR-induced responses including nuclear 
factor kappa-B (NF-κB), mitogen activated protein kinases (MAPKs), and IFN 
regulatory factors (IRFs). Activation of these downstream signalling pathways 
culminates in cellular responses including cytokine and chemokine production, 
maturation of APCs, and initiation of innate and adaptive immune responses (Figure 
2) [33, 46, 47]. 
 
TLR-induced signalling pathways can be largely divided into MyD88-dependent 
and -independent pathways. The adaptor protein MyD88 is involved in the 
signalling triggered by all TLRs except for TLR3. MyD88-dependent signalling 
through TLRs 2, 4, and 5 primarily result in MAPK and NF-κB-dependent 
proinflammatory responses. Moreover, MyD88-dependent type I IFN expression 
occurs through activation of intracellular TLR7, 8, and 9. The MyD88-independent 
pathways downstream of TLR3 and TLR4 signal through TRIF to activate IRFs 
which ultimately lead to type I IFN production [48, 49]. Type I IFN production is 
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traditionally associated with the recognition of nucleic acids of viral or bacterial 
origin by TLR3, 7, 8, or 9 or through internalized TLR4 via TRIF activation [48]. 
Recently, type I IFN production after TLR2 activation by whole bacteria or bacterial 
components [50, 51] was suggested to occur in endosomes after TLR2 
internalization [52, 53]. 
 
 
Figure 2.  Overview of the signal transduction via TLRs. Representative receptors for 
Gram-negative (TLR4) and Gram-positive (TLR2) bacterial ligands as well as 
for microbial nucleic acids (TLR9) are presented. TLRs can be expressed on 
the cell surface (TLR4, TLR2) or in intracellular compartments such as 
endosomes (TLR9). Ligand binding triggers recruitment of adaptor molecules 
and initiates a complex signal transduction pathway ultimately leading to the 
expression of cytokine genes. MyD88 is involved in all TLR signalling (except 
TLR3). It couples IL-1 receptor associated kinases (IRAKs) and transforming 
growth factor β-associated kinases (TRAFs) for downstream signalling. Ligand 
binding to TLR4 can also trigger MyD88-independent signalling pathways via 
TIR domain-containing adaptor inducing IFN-β (TRIF) and TRIF related adaptor 
molecule (TRAM). Depending on the receptor, MAPK, NF-κB, and IRF 
pathways can be activated. 
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Table 1.  Overview of human receptors of the innate immune system and their most 
common bacteria/virus –derived MAMPs. 
 
Receptor family PRR MAMP Origin of the ligand Cellular 
localization 
TLR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TLR1-TLR2 
TLR2-TLR6 
 
TLR2 
 
TLR3 
 
TLR4 
 
TLR5 
TLR7 
 
TLR8 
TLR9 
 
TLR10 
 
triacyl lipopeptides 
diacyl lipopeptides 
lipoteichoic acid 
peptidoglycan 
lipoarabinomannan 
dsRNA 
 
lipopolysaccharide 
envelope proteins 
flagellin 
ssRNA 
RNA 
ssRNA 
CpG DNA 
DNA 
unknown 
bacteria, mycobacteria 
mycobacteria 
bacteria 
bacteria 
mycobacteria 
RNA viruses 
 
bacteria 
viruses 
bacteria 
RNA viruses 
bacteria 
RNA viruses 
bacteria 
viruses 
bacteria  
viruses 
cell surface 
cell surface 
 
cell surface 
 
endosomes 
cell surface 
cell surface 
 
cell surface 
endosome 
 
endosome 
endosome 
 
cell surface 
RLR LGP2 
MDA-5 
RIG-I 
RNA 
RNA 
RNA 
viruses 
viruses 
bacteria 
viruses 
cytosol 
cytosol 
cytosol 
NLR NAIP5 
NLRC4 
NALP1 
 
NALP3 
 
 
NOD1 
NOD2 
flagellin 
flagellin 
muramyl dipeptide 
anthrax lethal toxin 
muramyl dipeptide 
RNA 
toxins 
diaminopimelic acid 
muramyl dipeptide 
ssRNA 
bacteria 
bacteria 
bacteria 
 
bacteria 
bacteria, viruses 
bacteria 
bacteria 
bacteria 
viruses 
cytosol 
cytosol 
cytosol 
 
cytosol 
 
 
cytosol 
cytosol 
Others AIM2 
DAI 
PKR 
dsDNA 
dsDNA 
dsRNA 
bacteria, viruses 
bacteria, viruses 
viruses 
cytosol 
cytosol 
cytosol 
Abbreviations: AIM2, absent in melanoma 2; DAI, DNA-dependent activator of IRFs; LGP2, laboratory of genetics and 
physiology 2; MAMP, microbe-associated molecular pattern; MDA5, melanoma differentiation-associated gene 5; NAIP5, 
neuronal apoptosis inhibitory protein 5; NALP, NACHT, LRR and PYD-domain containing protein; NOD, nucleotide-binding 
oligomerization domain; NLR, nucleotide-binding and leucine-rich repeat containing gene family receptor; NLRC, NLR 
family, CARD domain containing; PKR, protein kinase R; PRR, pattern recognition receptor; RIG-I, retinoic acid-inducible 
gene I; RLR, RIG-I-like receptor; TLR, Toll-like receptor. Adapted from: [34, 37, 38, 49, 54-56]. 
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2.2.3 Cytoplasmic surveillance of microbes and host danger signals 
 
TLR-independent recognition of pathogens is accomplished by cytosolic PRRs 
including NLRs and RLRs. RLRs sense cytosolic RNA which results in type I IFN 
mediated antiviral responses. Other cytoplasmic receptors such as DAI and AIM2 
contribute to inflammatory responses by recognizing cytosolic DNA leading to type 
I IFN production and proinflammatory responses (Table 1) [49]. 
 
NLRs consist of centrally located nucleotide-binding oligomerization (NOD), C-
terminal leucine-rich repeat (LRR), and N-terminal caspase recruitment (CARD) 
domains which mediate oligomerization, ligand sensing, and signal initiation, 
respectively [49]. Most of the NLR family members fall into two large subclasses; 
NODs and NALPs (NACHT, LRR, and pyrin-domain-containing proteins). The 
best-characterized NLRs are NOD1 and NOD2 which recognize for example 
bacterial peptidoglycan-derived components from Gram-negative and Gram-positive 
bacteria [57]. In addition to the activation of proinflammatory gene expression via 
NF-κB and MAPK activation, NOD proteins can also induce type I IFN signalling 
in response to bacteria [58]. 
 
Dysfunction of NOD proteins is associated with asthma, atopic eczema, and 
increased incidence of Crohn’s disease [59-61]. The increased Th1 responses in 
Crohn’s disease are probably due to disturbed immune responses to bacteria in the 
intestinal tract such as dysregulated NF-κB activation and Th1 polarization and 
decreased production of antimicrobial peptides [62, 63]. 
 
Other NLR proteins are components of large intracellular complexes, referred to as 
the inflammasomes that are important in the induction of host defence especially 
against bacterial infections. Inflammasomes act as platforms for the activation of 
caspase-1, a proteolytic enzyme responsible for the processing of IL-1β and IL-18 
precursors into their biologically active forms (Figure 3) [64, 65]. The best-
characterized inflammasomes are NLRC4, NALP3, and AIM2. Typical 
inflammasomes are composed of the adaptor ASC (apoptosis-associated speck-like 
protein containing CARD), pro-caspase-1, and NLR family member such as NLRC 
or NALP. Oligomerization through CARD-CARD interactions results in the 
activation of caspase-1. The inflammasome activation in macrophages requires two 
steps: the activation of NF-κB via TLRs to produce pro-IL-1β and pro-IL-18, and 
the activation of NALP and caspase-1 to cleave these inactive cytokines into their 
mature forms [66]. Each member of the inflammasome family recognizes different 
MAMPs through their respective NLR. 
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Figure 3.  Schematic representation of NALP3 inflammasome activation. The 
activation of NALP3 inflammasome leading to caspase-1 activation and 
cleavage of pro-IL-1β  and pro-IL-18 into their active forms is a two-step 
process. Signal 1 is needed for NF-κB activation and expression of NALP3, 
pro-IL-1β, and pro-IL-18. The first signal can be provided by microbial 
compounds or cytokines such as TNF-α. Signal 2 leads to the activation of 
NALP3, recruitment of adaptor proteins ASC and Cardinal, and activation 
of pro-caspase-1 into its active form. Activated caspase-1 cleaves the 
immature cytokines into their biologically active forms, IL-1β and IL-18. The 
second signal may result from the release of lysosomal compounds into the 
cytosol or from the decrease in intracellular K+ either through pore-forming 
toxins from bacteria or by the engagement of extracellular ATP with P2X7 
receptor. Adapted from [65]. 
 
 
NALP3 is upregulated in cells after TLR stimulation and it is activated in response 
to a variety of MAMPs and danger signals. It has been suggested that changes in 
intracellular ion concentrations induce inflammasome activation. The NALP3 
inflammasome is activated in response to ATP and previous reports show that 
priming of cells with LPS is necessary for ATP-induced inflammasome activation 
[67, 68]. It has been suggested that extracellular ATP with subsequent K+ efflux via 
P2X7 receptor triggers pore formation by pannexin 1 ultimately leading to the 
delivery of microbial products into the cytoplasm to activate the inflammasome [57].  
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Additionally, some bacterial pore forming toxins [69], reactive oxygen species [70], 
uric acid crystals [71], and the release of lysosomal compounds such as degradation 
products of phagocytosed bacteria into the cytosol can trigger inflammasome 
activation [72]. In addition, pathways other than caspase-1 activation have been 
proposed to regulate IL-1β and IL-18 processing [73-76]. 
 
TLRs and NLRs induce synergistic and simultaneous innate inflammatory responses 
due to shared ligands, distinct cellular locations, and independent signalling 
pathways. It is known that NALP1 interacts with NOD2 to mediate caspase-1 
activation in response to muramyl dipeptide (MDP) recognition. Thus, suggesting 
that also NOD2 has a role in both pro-IL-1β synthesis and maturation [49]. 
 
2.2.4 Uptake of microbes by phagocytosis and endocytosis 
 
Internalization of foreign particles or microbes into cells is divided into 
phagocytosis, macropinocytosis, and endocytosis (Figure 4). Macropinocytosis and 
phagocytosis are actin-dependent internalization mechanisms used in the uptake of 
fluids and large particles such as bacteria and dead cells. Phagocytosis is restricted 
to phagocytic cells such as macrophages, DCs, monocytes, and neutrophils. These 
cells possess phagocytic receptors, such as dectin 1, Fc, and complement receptors, 
which enable them to recognize targets either directly or indirectly via opsonization. 
Recognition is followed by the internalization of the microorganism into a 
phagosome, which then fuses with endosomes and ultimately lysosomes resulting in 
the degradation of the pathogen. Additionally, phagosomes can be formed inside 
cells during the engulfment of cellular organelles, cell debris, or intracellular 
microorganisms. This process is called autophagy. Phagocytosis forms a platform 
for TLR activation and is in many cases necessary for the activation of cytosolic 
PRRs and canonical and non-canonical inflammasomes. However, inflammatory 
responses such as cytokine production do not necessarily require internalization of 
the target [77-80]. 
 
Endocytosis is an important mechanism controlling the composition of the plasma 
membrane and the responses of cells to their environment in all cell types except in 
red blood cells. It is involved in many cellular events including changes in cell shape, 
nutrient uptake, and cell signalling. Several different types of endocytosis have been 
described based on the molecules that drive the process, including clathrin-
dependent, caveolin-dependent, and clathrin- and caveolin-independent endocytosis 
[81]. Extracellular cargos usually enter cells by several different endocytic pathways. 
Some internalization pathways are constitutively active, while others are triggered 
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by specific signals or exploited by pathogens to gain access into subcellular 
compartments. 
 
Many, but not all endocytic pathways require dynamin, a large GTPase, for pinching 
and release of vesicles from the plasma membrane (Figure 4) [81, 82]. Dynamin is 
necessary for many clathrin- and caveolin-dependent pathways and for vesicle 
formation from various intracellular organelles. Caveolin-mediated endocytosis is 
involved in delivering lipids, proteins, and pathogens into cells. Dynamin is also 
involved in some clathrin-independent pathways, such as internalization of cytokine 
receptor chains [83, 84]. Dynamin 1 and dynamin 2, the best-studied mammalian 
isoforms, interact with actin binding proteins and influence actin-comet formation 
on macropinosomes [85]. 
 
Invasive microorganisms have evolved several strategies for mediating their own 
uptake into the cells. Bacteria such as Listeria monocytogenes and Salmonella can 
induce their own uptake with the aid of bacterial virulence factors [82,83]. They also 
have mechanisms to escape from the host detection system, interfere with 
phagosome maturation, and to avoid phagosomal degradation by escaping into the 
cytosol. 
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Figure 4.  Schematic overview of the entry pathways into cells. Cells take up large 
particles by phagocytosis and fluids by macropinocytosis, both of which are 
actin-mediated processes. Cargoes can also be internalized via dynamin-
dependent and –independent pathways to be delivered to early endosomes. 
Dynamin is involved in clathrin and caveolin-dependent and -independent 
internalization mechanisms by mediating the pinching and release of the 
vesicle from the plasma membrane. The actions of dynamin can be 
inhibited with dynasore. Adapted from [81]. 
 
2.3 Cytokines 
 
Cytokines are soluble regulatory proteins that mediate the communication between 
cells to further modulate the innate and adaptive immune responses. Cytokines are 
secreted by various cell types and can act in autocrine or paracrine fashion to 
maintain homeostasis, control cell growth and differentiation, and to regulate the 
quality and magnitude of immune responses. Cytokines act through their specific 
cell surface receptors to activate intracellular signalling pathways resulting in gene 
expression of molecules that mediate immune responses. The cytokine system has 
two typical features, referred to as pleiotropy and redundancy. Thus, cytokines can 
target several cell types with cell type-specific effects and structurally unrelated 
cytokines can have similar and overlapping effects on target cells, respectively.  
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Under natural conditions, cells are exposed to a cocktail of several cytokines and 
other active components having synergistic and antagonistic interactions, meaning  
that the exposure of cells to multiple agents at the same time may lead to 
qualitatively different responses. The production of cytokines must be tightly 
regulated with a network of cytokine interactions with positive and negative 
feedback loops, since imbalance in the magnitude and duration of the immune 
response can be harmful or even lethal to the host. In cytokine production both 
transcriptional and translational regulation are essential. Transcription of most 
cytokine genes is regulated by multiple transcription factors activated by diverse 
ligands. In addition, the stability of cytokine mRNA is tightly regulated by 
degradation signals. Some cytokines, including IL-1β and IL-18, require 
posttranslational processing to be functionally mature. Moreover, the secretion of 
mature cytokines can also be a regulated process [86]. 
 
Cytokines are classified based on their structural and functional similarities to 
interleukin (IL), interferon (IFN), tumor necrosis factor (TNF), colony stimulating 
factor, transforming growth factor (TGF)-β, chemokine, and growth factor families. 
Classical proinflammatory cytokines including IL-1β, IL-6, and TNF-α are rapidly 
produced in response to microbial stimulation to enhance inflammatory reponses. 
Anti-inflammatory IL-10, on the contrary has immunosuppressive effects. Cytokines 
with chemotactic effects, chemokines, attract other effector cells to the site of 
inflammation and direct T cell responses [86]. Additionally, cytokines secreted by 
APCs direct the generation of Th responses towards Th1, Th2, Th17, or Treg 
responses. Thus, cytokines produced by various types of immune cells bridge innate 
and adaptive immunity to efficiently combat microbial infections and maintain 
tolerance. The complexity of the cytokine network reflects their ability to regulate 
the functions of different cell populations. 
 
2.3.1 Cytokines inducing Th1 immunity 
 
In response to microbial stimulation or infection both the innate and adaptive arms 
of the immune response become activated. Cytokines play a significant role in 
orchestrating both early and late host responses by inducing appropriate T cell 
polarization with microbial specificity. Polarized T cells modulate the immune 
response by producing cytokines that function as differentiation and growth factors 
for Th cells themselves and for other cell types. Th1 cytokines that strengthen cell-
mediated immune responses include IL-2, IL-15, IL-18, IL-21, IL-12 family 
cytokines, and IFNs. Eradication of most intracellular bacteria is regulated by IL-12, 
IL-18, and IFN cytokine families secreted by differentiated Th1 cells [87]. 
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IFN-γ  (Type II IFN)  
Probably the most important Th1 cytokine is the type II IFN, IFN-γ, which is mainly 
produced by NK cells, T cells, and to some extent by macrophages and DCs. IFN-γ 
is an important activator of macrophages and binds to a receptor composed of 
IFNγR1 and IFNγR2 subunits expressed on both lymphoid and non-lymphoid cells. 
The production of IFN-γ is synergistic with other Th1 cytokines and its production is 
stimulated by APC-T cell interactions. In macrophages and DCs the production of 
IFN-γ creates an autoregulatory loop that activates both cell types, primes DCs for 
efficient APC functions, and increases both IFN-γ and IL-12 production. This in turn 
leads to Th differentiation and adaptive immune responses where IFN-γ can amplify 
the induction of type I IFNs (IFN-α and IFN-β) to initiate innate and adaptive 
immune responses [87, 88]. 
 
The IL-12 family 
IL-12 is a heterodimeric cytokine composed of two subunits p35 and p40. The major 
cell types producing IL-12 are APCs such as macrophages and DCs [89, 90]. The 
IL-12 receptor consists of two chains, IL-12Rβ1 and IL-12Rβ2, and it is mostly 
present on the cell surface of NK cells and activated T cells, although there is some 
expression in macrophages and DCs. IL-12 links innate immunity to adaptive 
immunity by inducing the production of IFN-γ and favouring the differentiation of 
Th1 cells. It is unclear whether IL-12 is required for the initiation of Th1 responses. 
It may be more critical in inducing IFN-γ production at the later stages of infection 
[89]. 
 
IL-12p40 is produced in large excess over the IL-12p35 subunit and it is known to 
associate with p19 subunit to form another IL-12 family member, IL-23 [91]. IL-23 
binds to a receptor complex composed of IL-12Rβ1 and IL-23R chains. Similar to 
IL-12, IL-23 is primarily produced by phagocytes in response to microbial 
stimulation. The main target cells of IL-23 are NK cells and T cells but its receptors 
are also expressed at low levels on monocytes, macrophages, and DCs [87, 90, 92]. 
However, in contrast to IL-12, which is important in inducing Th1 responses, IL-23 
also plays a role in the survival and maintenance of Th17 cells. These cells produce 
IL-17 and induce the production of proinflammatory cytokines which can play a role 
in the development of autoimmunity or protective responses during infection. Th17 
cells improve mucosal barrier function and mediate protective mucosal host defense 
against microbes [18, 92]. 
 
The third IL-12 family member IL-27, composed of EBI3 and p28 subunits [93], has 
a proinflammatory and a limiting role in the intensity and duration of innate and 
adaptive immune responses [18, 94]. IL-27 is produced primarily by macrophages, 
and DCs. IL-27 signals through a receptor composed of two subunits; gp130 and a 
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novel member of the type I cytokine receptor family, IL-27RA (also known as the T 
cell cytokine receptor TCCR or WSX1) which shows strong homology to the IL-
12Rβ2 chain [18, 87]. Elevated IL-27 levels have been associated with Crohn’s 
disease and psoriasis. Additionally, single nucleotide polymorphism in the gene 
encoding IL-27 may increase the risk for autoimmune diseases such as asthma and 
inflammatory bowel disease (IBD) [94]. 
 
The expression of the subunits of IL-12 family cytokine genes is independently 
regulated, and the formation of biologically active cytokines requires the synthesis 
of both subunits within the same cell. All three IL-12 family members mediate 
immune responses by activating the Janus Kinase (JAK)/Signal transducer and 
activator of transcription (STAT) pathway with specific differences in the activation 
and phosphorylation of different STAT molecules [92, 94]. 
 
2.3.2 Proinflammatory cytokines 
 
TNF-α  
TNF-α is a proinflammatory cytokine expressed especially by activated 
macrophages and lymphocytes. It contributes to different cellular responses 
including apoptosis and expression of genes involved in early inflammatory immune 
responses and adaptive immune responses. TNF-α is expressed as a membrane-
bound or secreted ligand that is bioactive as a trimer. Most of the TNF-induced 
responses are transmitted via the TNFR superfamily members TNFR1 or TNFR2. 
Depending on the cellular milieu, TNF-α can induce either NF-κB-mediated 
survival and proinflammatory pathway or an apoptotic response through caspases 
[95, 96]. 
 
IL-1β  
IL-1β is a proinflammatory cytokine able to stimulate the expression of genes 
associated with inflammatory responses. The primary sources of IL-1β are blood 
monocytes, tissue macrophages, and DCs. IL-1β can be produced as a precursor 
molecule after bacterial stimulation and it is cleaved into its biologically active form 
by caspase-1 after inflammasome activation. The most important enzyme 
responsible for the cleavage of IL-1β is intracellular caspase-1 although, some serine 
proteinases including elastase, cathepsin G, proteinase 3, and metalloproteinases can 
also process IL-1β [76, 97]. IL-1β contributes to host defence against infection by 
activating neutrophils and macrophages to engulf pathogens and by initiating Th1 
and Th17 adaptive immune responses. IL-1β also inhibits Th1 polarization by 
inhibitig IFN-γ production, thus favouring Th17 polarization [97]. 
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2.3.3 Th2 and anti-inflammatory cytokines 
 
The most important Th2 type cytokines, IL-4, IL-5, IL-10, and IL-13, are involved 
in the generation of antibody-mediated immune responses. These cytokines are 
produced to eliminate helminths and other extracellular organisms. However, their 
excessive production is also involved in autoimmune and atopic diseases. 
 
IL-4, IL-10, and TGF-β are anti-inflammatory cytokines that suppress inflammatory 
reactions by inhibiting the expression of proinflammatory cytokines and attenuating 
the stimulatory effects of IL-12 and IFN-γ. IL-10 is the most important anti-
inflammatory and regulatory cytokine having a crucial role in limiting the immune 
response to pathogens and preventing the damage to host cells [98-100]. However, 
also immunostimulatory effects of IL-10 have been observed in some circumstances. 
IL-10 is expressed by cells of the innate and adaptive immune systems. By acting on 
T cells, DCs, and macrophages IL-10 has the ability to downregulate cytokine 
production and inhibit the development of Th1 type immune responses as well as 
Th2 and allergic responses. IL-10 inhibits the synthesis of several cytokines including 
IL-1β, IL-6, IL-12, and TNF-α, and downregulates IgE production [101, 102]. 
 
2.3.4 Interferons 
 
Interferons are proteins with antiviral activity as well as they have the ability to 
regulate the functions of innate and adaptive immune cells. Interferons are classified 
into three classes (type I, type II and type III IFNs) based on the receptor complex 
they use for signalling. After receptor binding all IFNs activate the JAK/STAT 
pathway to transduce inflammatory signals. The production and regulation of IFNs 
involve a positive feedback loop, which can significantly enhance IFN responses 
[103-105]. 
 
Type I IFNs 
The major subtypes of type I IFNs are IFN-α and IFN-β. They are produced in 
response to microbial stimulation leading to the expression of several hundred IFN-
stimulated genes (ISGs) [106, 107]. Type I IFNs are produced by almost all cell 
types and they utilize a receptor that consists of IFNAR1 and IFNAR2 chains for 
signalling. Especially pDCs produce high amounts of type I IFNs in response to 
viral stimulation in a MyD88-dependent manner. This may be due to their high 
expression of TLR7 and 9 [108]. Also macrophages and DCs produce type I IFNs in 
response to activation of TLR3 and TLR4 pathways via the adaptor protein TRIF 
[109] and in response to TLR2 activation via MyD88 [50, 52, 110]. 
 
Activation of Innate Immune 
Responses by Non-pathogenic 
and Pathogenic Bacteria in 
Human Leukocytes 
Review of the literature 
 
THL — Research 138 • 2014 36 
 
In addition to viral stimulation, also bacteria can induce type I IFN production [111-
113]. Type I IFNs can regulate the development of adaptive immunity by promoting 
DC maturation and Th1 polarization [114]. During bacterial infections, type I IFNs 
can have different functions including a role in antibacterial resistance [106]. IFNs 
are shown to be involved in host resistance to group B streptococci, pneumococci 
[115], and Streptococcus pyogenes (GAS) [116], but detrimental to host in Listeria 
monocytogenes infection [117, 118]. 
 
Type II IFN 
The only member of the type II IFN family, IFN-γ is an important Th1 cytokine and 
is discussed previously in the context of cytokines inducing Th1 immunity. 
 
Type III IFNs 
Type III IFNs are the most recently found IFN family members, also known as IFN-
λs. This class consists of four homologous genes IFN-λ1-4 [119-121]. IFN-λs signal 
through a receptor composed of IL10R2 and IFNλR1 chains principally restricted to 
cells of epithelial origin. Type III IFNs activate the same intracellular signalling 
pathway as type I IFNs. Thus, they have rather similar biological activities [88]. 
 
2.3.5 Chemokines 
 
Cytokines with chemotactic properties are called chemokines. Members of the 
chemokine superfamily can be grouped into four subfamilies, CC, CXC, CX3C, and 
XC, based on the arrangement of their N-terminal cysteine residues. Most 
chemokines belong to CC or CXC classes, where the first two cysteines are either 
adjacent or separated with one amino acid, respectively. Chemokines can also be 
classified into inflammatory and homeostatic chemokines although some of them 
can exhibit both functions. Inflammatory chemokines that mainly attract 
macrophages and neutrophils create a chemical gradient to guide cells to the site of 
inflammation. Homeostatic chemokines are produced constitutively in the bone 
marrow and thymus to regulate leukocyte hematopoiesis and to guide leukocyte 
migration to the secondary lymphoid organs. Chemokines can be involved in both 
inflammatory reactions against pathogens and in autoimmunity. Different leukocyte 
subsets express distinct chemokine receptor patterns on their surface forming the 
basis for the selective activities of chemokines. To complicate the chemokine 
network, they show redundancy and binding promiscuosity and some chemokines 
can act as antagonists for other ligand-receptor pairs [105, 122-125]. 
 
Chemokines have an important role in regulating DC trafficking during 
inflammation. Chemokines including CXCL10 and CCL20 are produced by DCs in 
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response to microbial stimuli [126, 127]. The binding of CCL20 to its receptor CCR6 
on the surface of immature DCs guides these cells to the site of infection. Ligand 
binding and antigen uptake during infection downregulate CCL20 chemokine 
receptor expression on DC surface. Thus, decreasing the ability of DCs to respond to 
inflammatory chemokines. Upon maturation DCs start to express CCR7, a receptor for 
CCL21 and CCL19 which attract naïve T cells [126-129]. The expression of CCL19 
and its receptor by mature DCs lead to DC migration to the local draining lymph 
nodes and attract naïve T cells into their vicinity to be activated [125, 127, 129, 130]. 
 
 
Table 2.  Classification of the cytokines and chemokines measured in this thesis. 
 
Cytokine Pro- 
inflammatory 
Anti- 
inflammatory 
Th1 Th2 Regulatory 
IL-1β x     
IL-6 x   x  
IL-10  x   x 
IL-12 x  x   
TNF-α x     
IFN-β x     
IFN-γ   x   
Chemokine      
CCL19 x     
CCL20 x     
CXCL8 x     
CXCL10 x     
 
2.3.6 Regulation of cytokine production by SOCS3  
 
Suppressor of cytokine signalling (SOCS) proteins are intracellular molecules 
induced in response to multiple stimuli including cytokines, growth factors, and 
TLR ligands. They interact with cytokine receptors and signalling molecules to 
regulate macrophage and DC activation and T cell differentiation and development 
via a negative feedback loop [131, 132]. SOCS proteins have been shown to regulate 
the responses of immune cells to cytokines. The expression of SOCS3 is regulated 
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by both anti-inflammatory and proinflammatory cytokines, especially IL-1β, TGF-β, 
IL-10, and IL-6 [133, 134]. SOCS proteins inhibit signalling through JAK/STAT 
pathway and participate in regulating the strength, duration, and specificity of 
cytokine responses (Figure 5). There are eight SOCS proteins in the human genome, 
all containing an N-terminal domain, a central SH2 domain which mediates SOCS 
binding to tyrosine phosphorylated signalling molecules, and a C-terminal SOCS 
box involved in targeting bound proteins to ubiquitination and proteasome degradation. 
SOCS1 and SOCS3 have shorter N-terminal domains than other family members. This 
allows them to interact directly with JAKs and inhibit their catalytic activity [131, 132]. 
 
 
 
 
Figure 5.  Schematic representation of the feedback inhibition of cytokine 
signalling by SOCS3. Ligand binding to TLRs result in the activation of 
transcription factors including NF-κB, MAPKs, and IRFs. After translocation 
into the nucleus these factors bind to the promoter element of cytokine 
genes, such as IL-10 and initiate mRNA transcription. IL-10 is produced 
and secreted and affects in an autocrine or paracrine fashion by binding to 
its receptor on the cell surface. Binding of IL-10 activates the JAK/STAT 
signalling pathway to activate SOCS3 gene expression. This ultimately 
leads to the binding of SOCS3 to the cytokine receptor chains which 
interferes with JAK activation, thus inhibiting JAK/STAT signalling. 
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2.4 Overview of probiotic bacteria  
 
Probiotic bacteria are defined by the World Health Organization as ‘live 
microorganisms which, when administered in adequate amounts, confer health 
benefit on the host’ [135]. 
 
The probiotic strains which are used for human consumption are non-pathogenic 
bacteria mostly derived from beneficial commensals of human origin. For historical 
reasons most probiotics belong to the genera Lactobacillus and Bifidobacterium,  
which are generally used in dairy fermentation. Probiotic bacteria are thought to 
confer most of their health promoting activities in the gastrointestinal tract, where 
they can act through diverse mechanisms. They can improve barrier function, 
balance the composition or function of the commensal microbiota, inhibit the growth 
of other bacteria by secreting antimicrobial compounds, and compete for mucosal 
binding sites and nutrients with other bacteria. Probiotics can also mediate their 
beneficial effects via modulating the pro- and anti-inflammatory cytokine secretion 
by immune cells [136-139]. 
 
The possible beneficial health effects of probiotics on various diseases have been 
assessed in multiple clinical studies [140-142] and promising results have been 
obtained. Lactobacillus rhamnosus GG is one of the most intensively studied 
probiotic bacterium and several clinical studies support its beneficial effects on the 
host [143-149]. The effects of probiotic bacteria on the reduction of the risk of 
atopic diseases such as allergy and eczema have been extensively studied [136, 144, 
145, 150] and potential beneficial effects have been observed. In addition, their 
ability to prevent or ameliorate the symptoms of various gastrointestinal disorders 
including rotaviral [143, 146, 148, 151] and antibiotic-associated [147] diarrhea 
have been studied. There are also promising results in amelioration of the symptoms 
of other gastroenterological disorders such as IBD and IBS [152-154]. The effects of 
probiotic bacteria in association with other than gut-related diseases such as dental 
caries, pancreatitis, vaginal and urinary tract infections, cancer and airway infections 
have also been suggested [155]. Despite these numerous studies with encouraging 
results, the molecular mechanisms behind these actions are less well understood. 
 
Probiotic bacteria are usually non-pathogenic members of the normal 
gastrointestinal microbiota. In spite of a few reports of unfavourable effects in 
immunocompromised subjects, such as Lactobacillus septicaemia [156, 157] and 
detrimental effects on pancreatitis patients [158], probiotic therapy is generally 
considered as safe [159]. The use of bacterial strains in food is carefully evaluated 
and many Lactobacillus, Lactococcus, Leuconostoc, Bifidobacterium, Streptococcus,  
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and Propionibacterium strains have been determined safe by the European Food 
Safety Authority (EFSA) [160]. Although, probiotics are intensively studied, their 
safety as therapeutic substances has not been systemically examined. For example, 
many Lactobacillus strains carry antibiotic resistance genes [161] and there is a 
theoretical possibility that probiotic bacteria could transfer these genes to the 
commensal microbiota [162] or generate unfavourable metabolites in the intestine. 
 
There are many challenges in probiotic clinical studies. The beneficial effects of 
probiotic bacteria are mostly characterized in immunocompromised or health-
challenged persons. However, the baseline health status of a person likely affects the 
outcome in clinical trials. Less attention has been paid to their effects on healthy 
humans, who are most likely to consume probiotic products. In addition, healthy 
persons are shown to differ from allergic and IBS patients in their gut microbiota 
composition [163-167], which might affect the results. Moreover, the actions of 
probiotic bacteria are shown to be host-, strain-, and dose-specific and their 
biological effects cannot be concluded based on the results from another strain or 
species [168-170]. 
 
2.5 Overview of Streptococcus pyogenes pathogenicity 
 
Streptococcus pyogenes (Group A streptococcus, GAS) is a Gram-positive human 
pathogen. It causes mostly diseases limited to the pharyngeal mucosa or skin such as 
tonsillitis and impetigo, but can also cause invasive infections such as erysipelas, 
sepsis, toxic shock syndrome, and necrotizing fasciitis. Although, mild non-invasive 
GAS infections can be easily cured by penicillin, GAS is among the ten most 
common causes of death from infectious disease worldwide. It is an important cause 
of morbidity and mortality worldwide with over 650 000 invasive GAS infections 
and 160 000 deaths each year [171]. Untreated infections can lead to severe post-
streptococcal diseases such as glomerulonephritis and rheumatic fever [171, 172]. 
 
All GAS infections are characterized by a robust inflammatory reaction. The 
bacterium encodes multiple virulence factors that in various ways interfere with the 
host immune system and clearance mechanisms. These virulence factors can disrupt 
neutrophil recruitment to the infection site by degrading chemokines regulating 
neutrophil migration. In addition, virulence factors help the bacterium to avoid and 
escape the host surveillance system by e.g. preventing complement activation and 
interfering with the recognition or phagocytosis of the bacterium [173, 174]. Two 
important streptococcal virulence factors are the extracellular enzymes called 
streptolysins that can form pores in host cell membranes leading to apoptosis. In 
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addition, streptolysins facilitate the escape of the bacterium from the endosome-
lysosome pathway [175, 176]. 
 
The streptococcal M protein is used for the serotypic classification of GAS. It is 
encoded by the emm gene of which more than 200 sequence types have been 
identified. The T1M1 serotype is one of the most frequently isolated serotypes in 
severe invasive GAS infections [173] and has the ability to protect the bacterium 
from phagocytosis by inhibiting complement deposition on the bacterial surface. 
 
2.6 Sendai virus 
 
Sendai virus, also known as murine parainfluenza type I, is an enveloped negative-
stranded ssRNA virus causing severe respiratory infections in mice. It belongs to the 
genus Respirovirus of the Paramyxoviridae family. Sendai virus is considered non-
pathogenic in humans [177, 178]. 
 
Sendai virus fuses directly with the plasma membrane to enter the host cells [179]. It 
replicates in the cytoplasm where virus-derived molecules such as viral nucleic acids 
can be detected by intracellular PRRs to activate intracellular signalling cascades. 
The strong antiviral responses induced by Sendai virus make it a useful tool for 
analysing host cell signalling pathways [178, 180, 181]. 
 
2.7 Interactions of bacteria with phagocytes in the intestine 
 
One place where phagocytic DCs and macrophages come into contact with probiotic, 
commensal, and pathogenic bacteria is at the mucosal surfaces of the gut. The 
intestine is loaded with microbes and microbe-derived components and it is essential 
to limit the inflammatory responses induced in these areas of the body. In addition to 
capturing microbes that have crossed the epithelial barrier to the lamina propria, 
DCs can extend their appendices trough the tight junctions between epithelial cells 
and sample bacteria from the gut lumen via their cell surface receptors such as TLR2 
and TLR4 [24, 182]. Probiotic bacteria are believed to have the ability to modulate 
the immune system in the gut. These effects may be elicited through direct 
interactions with the epithelial cells or resident DC and macrophage populations. 
The different abilities of probiotic bacteria to affect immune responses may be 
associated with bacterial cell wall structure, secreted bacterial factors, or their 
unmethylated CpG DNA content [183-187]. 
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The intestinal immune system is the largest and most complex part of the immune 
system protecting against potential pathogens and giving tolerance to ingested food 
antigens and microbiota that inhabits the gut [5]. The challenge is to discriminate 
harmless antigens such as commensal bacteria and food antigens from invasive 
microorganisms and these mechanisms remain to be elucidated. However, the 
differential distribution of TLRs on the apical and basolateral surfaces of epithelial 
cells helps to detect bacteria that have crossed the epithelial cell layer and to initiate 
appropriatae immune responses [188, 189]. In addition, the suppressed NF-κB 
activation from apical surfaces might play a role in gut homeaostasis [189]. 
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3 Aims of the study 
Macrophages and DCs play a central role in the immune responses induced by 
microbes. They are the key cell types under the epithelial cell layers throughout the 
body and sample the environment in case of intruders. Despite intensive research in 
recent years, the mechanisms how probiotic bacteria elicit their health promoting 
effects are poorly characterized. In addition, the mechanisms of Streptococcus 
pyogenes infections are not fully understood. 
 
The specific objectives of this study were: 
 
1. To analyse and compare the cytokine responses induced by multiple 
probiotic bacteria, potentially probiotic bacteria, and pathogenic S. 
pyogenes in DCs and macrophages. 
 
2. To study the role of anti-inflammatory IL-10 in the responses induced by 
non-pathogenic bacteria. 
 
3. To study the mechanisms of S. pyogenes -induced inflammatory responses 
and the role of streptococcal virulence factors and dynamin-dependent 
endocytosis in the activation of host innate immune responses. 
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4 Materials and methods 
4.1 Human primary cell cultures 
4.1.1 Monocyte-derived macrophages and dendritic cells (DCs) 
 
Leukocyte-rich buffy coats from healthy blood donors were supplied by the Finnish 
Red Cross Blood Transfusion Service (Helsinki, Finland). Each experiment was 
carried out with cells obtained from three or four blood donors. Human peripheral 
blood mononuclear cells (PBMC) were isolated by density-gradient centrifugation 
over a Ficoll-Pague Gradient (Amersham Biotech, Uppsala, Sweden) and washed 
with phosphate buffered saline (PBS). Monocytes were purified from PBMCs by 
allowing them to adhere to plastic plates for 1 h at 37°C, after which non-adherent 
cells were removed by washing with PBS. 
 
To differentiate monocytes into macrophages, cells were cultivated for 7 days in 
serum-free macrophage medium (Gibco) supplemented with antibiotics (penicillin 
0.6 µg/ml, streptomysin 60 µg/ml) and GM-CSF (10 ng/ml) (Biosource, Camarillo, 
CA, USA). Fresh medium was changed every two days. 
 
To obtain moDCs, PBMCs were further purified by Percoll-gradient centrifugation 
and magnetic depletion (Dynal, Oslo, Norway) of contaminating T and B cells. Cells 
were then allowed to adhere to plastic plates for 1 h at 37°C, after which non-
adherent cells were removed by washing with PBS. Cells were cultivated for 6-7 
days in RPMI-1640 medium supplemented with antibiotics (penicillin 0.6 µg/ml, 
streptomysin 60 µg/ml), 2mM glutamine, 20 mM HEPES, 10 % FCS, 10 ng/ml GM-
CSF, and 20 ng/ml IL-4. Fresh medium was added every two days (Figure 6). 
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Figure 6.  Differentiation of macrophages and dendritic cells from monocytes. 
 
4.2  Microbes 
4.2.1 Probiotic and potentially probiotic bacteria 
 
Five probiotic strains and six potentially probiotic bacterial strains were obtained 
from Valio Research Centre (Helsinki, Finland). Bacteria were stored in skimmed 
milk at -70°C and passaged three times (except for Bifidobacterium strains which 
were passaged four times) before they were used in experiments. Bacteria were 
grown to the end of logarithmic growth phase before they were collected by 
centrifugation and used in experiments. The number of bacteria was determined by 
counting in a Petroff-Hausser chamber. Bacterial strains used in this thesis are 
described in tables 3 and 4. 
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Table 3.  Non-pathogenic bacteria used in these studies. 
 
Bacterial species/ 
subspecies 
Abbreviation ATCC/DSM 
number 
Culture media Growth 
conditions 
Use 
Bifidobacterium      
Bifidobacterium animalis subsp. 
lactis Bb12 
Bifidobacterium breve  Bb99 
 
Bifidobacterium longum 1/10  
Bb12 
 
Bb99 
 
1/10 
DSM 15954  
 
DSM 13692  
 
NA 
MRS medium1 
with cysteine2  
 
+ 37°C, 
anaerobic 
 
 
probiotic  
 
probiotic 
 
none 
Lactobacillus      
Lactobacillus rhamnosus GG 
 
Lactobacillus rhamnosus LC705 
 
Lactobacillus helveticus 1129 
 
 
Lactobacillus helveticus Lb 161 
LGG 
 
LC705 
 
1129 
 
 
161 
ATCC 53103  
 
DSM 7061  
 
DSM 13137  
 
 
NA 
MRS medium1 
 
 
+ 37°C, 
aerobic 
+ 37°C, 
aerobic 
+ 42°C, 
aerobic 
 
+ 42°C, 
aerobic 
probiotic 
 
probiotic 
 
cheese, 
fermented 
milk 
cheese 
Lactococcus      
Lactococcus lactis subsp. cremoris 
ARH74 
ARH74 DSM 18891 Calciumcitrate 
agar3 and M17 
broth4 with lactose5 
+ 37°C, 
aerobic 
sour whole 
milk product 
(viili) 
Leuconostoc      
Leuconostoc mesenteroides 
subsp. cremoris PIA2 
PIA2 DSM 18892 MRS medium1 
 
+ 22°C, 
aerobic 
sour whole 
milk product 
(viili)  
Propionibacterium      
Propionibacterium freudenreichii 
subsp. shermanii JS 
PJS DSM 7067 Propionimedium3 + 30°C, 
aerobic 
probiotic, 
cheese 
Streptococcus      
Streptococcus thermophilus THS 
 
THS 
 
NA 
 
M17 agar1 
with lactose5 
and M17 broth4 
+ 37°C, 
aerobic 
yoghurt  
 
ATCC, American Type Culture Collection; DSM, German Collection of Microorganisms; MRS, de Man, Rogosa and Sharpe 
medium.1Lab M, Topley House, Lancashire UK; 2Merck, Darmstadt, Germany; 3Valio Ltd, Helsinki, Finland; 4Difco, Becton 
Dickinson, MD, USA; 5J.T. Baker B.V., Deventer, Holland. 
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4.2.2 Streptococcus pyogenes 
 
Pathogenic Streptococcus pyogenes serotype T1M1 (IH32030) [190], isolated from 
a child with bacteremia, was from the collection of the National Institute for Health 
and Welfare (Helsinki, Finland). Streptococcus pyogenes M1 (ATCC 700294) is a 
clinical strain originally isolated from infected wound. S. pyogenes mutants lacking 
slo (EC997) [191] or sagA (EC695), the genes encoding major streptococcal 
virulence factors streptolysin O (SLO) and streptolysin S (SLS), respectively, were 
provided by Emmanuelle Charpentier (Umeå University, Sweden). Heat inactivation 
of bacteria was performed in 95°C dry heat block for 5 min and UV inactivation by 
exposing bacteria to UV light at an energy level of 2 x 0,12J. Complete inactivation 
of bacteria was verified by sheep blood agar plate counting method. S. pyogenes –
strains used in the study are summarized in table 4. 
 
Table 4.  Pathogenic bacteria used in these studies. 
 
Bacterial strains 
 
Abbreviation ATCC 
number/source 
Culture 
media 
Growth 
conditions 
Used in 
study 
Streptococcus pyogenes 
(IH32030) 
 
Streptococcus pyogenes 
Streptococcus pyogenes (EC997) 
Streptococcus pyogenes (EC695) 
GAS 
 
 
GAS 
SLO - 
SLS - 
National Institute 
for Health and 
Welfare 
ATCC 700294 
E. Charpentier 
E. Charpentier 
Sheep 
blood agar1,  
Nefrit broth2 
+ 37°C 
aerobic 
I, II 
 
 
III 
III 
III 
1Oxoid, Ogdensburg, NY, USA; 2National Institute for Health and Welfare, Helsinki, Finland. 
 
4.2.3 Sendai virus 
 
Sendai virus (Cantell strain, National Institute for Health and Welfare, Helsinki, 
Finland) was grown in embryonated chicken eggs and stored in -70°C. The 
hemagglutination titer of the virus was 4096 and the infectivity of the stock in 
macrophages and DCs was 6 x 109 pfu/ml. Cells were infected with multiplicity of 
infection (MOI) value of 5. 
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4.3 Reagents 
4.3.1 Cytokines 
 
For priming experiments, cytokines were added to cell culture media 16 h prior to 
bacterial stimulation. Cytokines used in the thesis are summarized in table 5. 
 
Table 5.  Cytokines used in these studies. 
 
Cytokine Concentration used Source Used in publication 
TNF-α 10 ng/ml Biosource I 
IL-6 10 ng/ml Biosource I 
IL-10 10 ng/ml R&D Systems II 
IFN-γ 100 IU/ml Finnish Red Cross I 
 
4.3.2 Inhibitors 
 
Commercial pharmacological inhibitors were used to inhibit cell signalling 
pathways and other cellular processes. Inhibitors and other reagents used in the 
experiments are summarized in table 6. 
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Table 6.  Pharmacological inhibitors and other reagents used in these studies. 
 
Signalling 
inhibitor 
Concentration 
used 
Target Source Used in 
publication 
CsA 0.2 or 1 µg/ml NFAT Alexis Biochemicals I 
Ly294002 10 or 50 µM PI3K Calbiochem I,II 
SB202190 2 or 10 µM p38 MAPK Calbiochem I, II 
SP600125 10 µM JNK MAPK Alexis Biochemicals II 
PD98059 2 or 10 µM ERK MAPK Calbiochem I, II 
PDTC 50 or 100 µM NF-κB Alexis Biochemicals I, II 
Other 
inhibitors 
    
CHX 30 µg/ml de novo protein 
synthesis 
Sigma II 
Dynasore 80 µM dynamin [85] Sigma III 
Other reagents     
Pam3CSK4 100 ng/ml TLR1/2 ligand InvivoGen II 
LPS (0111:B4)  100 ng/ml TLR4 ligand Sigma II 
anti-IL10 1 µg/ml IL-10 R&D Systems II 
CHX, cycloheximide; CsA, cyclosporine A; LPS, lipopolysaccharide; MAPK, mitogen activated protein kinase; NFAT, 
nuclear factor of activated T cells; NF-κB, nuclear factor kappa-B; Pam3CSK4, tripalmitoyl-S-glyceryl-cysteine; PDTC, 
pyrrolidine dithiocarbamate; PI3K, phosphoinositide 3-kinase. 
 
4.4 mRNA analyses 
4.4.1 Northern blot analysis 
 
Total cellular RNA was isolated by using an RNA purification kit (Qiagen). 
Samples containing equal amounts of RNA were separated by size on 1% 
formaldehyde-agarose gels and transferred onto Hybond-N-membranes (Amersham 
Biosciences). Membranes were hybridized with human cytokine cDNA probes 
labelled with [α-32P] deoxy-adenosine 5’-triphosphate (3000 Ci/mmol, Amersham 
Pharmacia Biotech) using a random-primed DNA labelling kit (Fermentas). 
Membranes were hybridized, washed, and exposed to Kodak X-Omat AR-films. 
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4.4.2 Quantitative RT-PCR 
 
Total cellular RNA was isolated with an RNA purification kit (Qiagen). Synthesis of 
cDNA was performed using Multiscribe RT (Applied Biosystems) with oligo-d(T) 
primers. Amplification of cDNA was performed using Master Mix Buffer with 
Assays-on-Demand gene expression primers and probes (Applied Biosystems). 
Samples were amplified in duplicate with MxPro 3005P (Stratagene) and 
normalized against β-actin. Relative amounts of mRNA were calculated with the ΔΔ 
comparative threshold (Ct) method [192]. 
 
4.5 Protein analyses 
4.5.1 ELISA 
 
Cytokine levels from cell culture supernatants were analysed by a sandwich ELISA 
method with antibody pairs and standards obtained from BD Pharmingen, R&D 
Biosystems or Biosite. Also a FlowCytomix bead assay (Bender Medsystems) was 
used for cytokine measurements. 
 
4.5.2 Flow cytometry 
 
Cells were collected, washed with PBS, fixed with paraformaldehyde, and stored in 
2% FCS/PBS at 4°C before staining. Cell surface protein markers were stained with 
FITC- and PE-conjugated monoclonal antibodies and isotype mached control 
antibodies (Caltag Laboratories). Samples were analyzed with FACScan cytometer 
and Cell Quest software (Becton Bickinson). 
 
4.5.3 Western blot analysis 
 
Whole cell lysates were prepared in Laemmli sample buffer for Western blot 
analysis. The proteins were separated on 15% SDS-PAGE, transferred onto 
Immobilon-P membranes (Millipore), and stained with specific antibodies. 
Activation of Innate ?mmune 
Responses by Non-pathogenic 
and Pathogenic Bacteria in 
Human Leukocytes 
  
 THL — Research 138 • 2014 53 
 
 
5 Results and discussion 
The results of this study highlight the complex interactions between the host, 
commensal microbiota, and pathogenic bacteria. We have approached this issue with 
in vitro experiments that enable to study a selected microbe in highly controlled 
experimental conditions and the analysis of their effects at molecular and cellular 
level. It must be, however, taken into account that in vitro differentiated cells and 
cell lines may differ from their in vivo counterparts when taken away from their 
original milieu including normal microbiota, epithelial cells, and other blood cells. 
In addition, a disadvantage of in vitro studies is their limited duration. Despite these 
limitations, the advantages of in vitro studies are undeniable. In this study, our goal 
was to clarify the mechanisms of the beneficial effects of probiotics on the host by 
using human in vitro differentiated macrophages and DCs that most likely encounter 
these microbes in vivo. In addition, the ability of GAS and its virulence factor 
defective mutant derivatives to initiate innate immune responses and the role of 
dynamin-dependent endocytosis in these events were also analysed. The cells used 
in this study resemble immature DCs and macrophages that are recruited from blood 
to the infection site. Mucosal DCs primarily consist of myeloid DCs, which are 
likely of monocyte origin. 
 
5.1 Maturation of DCs (I) 
 
Immature DCs mature into APCs upon encountering microbes or foreign antigens, 
in this case different species of non-pathogenic or pathogenic bacteria. The 
interactions of host cells with bacteria most likely take place at the mucosal surfaces 
of the gastrointestinal and respiratory tract or through an injury in the mucosal 
epithelial cell layer or the skin. Non-pathogenic or pathogenic bacteria can be 
ingested by macrophages and DCs to initiate innate and adaptive immune responses. 
Mature DCs secrete cytokines and chemokines and express cell surface molecules 
such as HLA class II and costimulatory molecules CD80, CD83, and CD86. In 
addition to their role in innate immunity, matured DCs migrate from peripheral 
tissues into local lymph nodes to present antigens to naïve T cells to initiate adaptive 
immune responses. 
 
This study was initiated since previous studies had provided evidence on the ability 
of pathogenic bacteria and their purified components to enhance DC maturation 
[193-195]. There was also data available on the ability of non-pathogenic 
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lactobacilli and bifidobacteria [168, 196-199] including LGG [200] to modulate 
human DC functions. Because of the growing interest towards probiotic bacteria, we 
wanted to compare the ability of other probiotic and potentially probiotic Gram-
positive bacteria used in food industry to stimulate human DCs. The ability of 
various bacteria to induce DC maturation, cytokine production, and the expression 
of other inflammatory genes was analysed and compared with those induced by 
pathogenic GAS. 
 
We went on to study the ability of various non-pathogenic bacteria to induce human 
DC maturation. In a previous report it was shown that both the Lactobacillus 
rhamnosus strain LGG and pathogenic GAS were able to induce DC maturation 
[200]. Although, both LGG and GAS clearly induced CD83 and CD86 expression 
on the cell surface, LGG-stimulated cells showed lower expression levels compared 
with GAS-stimulated cells. It was of interest that LGG could efficiently induce DC 
maturation and therefore we analysed whether other non-pathogenic bacteria had the 
same ability. We showed that non-pathogenic bacteria representing Streptococcus, 
Bifidobacterium, and Lactococcus genera induced DC maturation as efficiently as 
pathogenic GAS as evidenced by increased expression of CD86 and HLA class II 
molecules on the cell surface (Fig. 3 in I). These molecules were induced in a 
bacterial dose-dependent manner already with a low bacteria:DC ratio of 2:1. 
However, it has been reported previously that different clinical GAS isolates have 
distinct abilities to induce DC maturation. GAS strains that produced large amounts 
of SLO and hyaluronic acid capsular polysaccharide failed to induce DC maturation 
[201]. Thus, our results and those by others suggest that the expression of DC 
maturation markers can be upregulated by both pathogenic and non-pathogenic 
bacteria and the ability of some bacterial strains to inhibit DC maturation could be a 
feature of some pathogenic bacteria or bacterial strains to avoid host immune 
responses. Our results showing the expression of costimulatory molecule CD86 in 
addition to HLA class II suggests that also DCs stimulated with non-pathogenic 
bacteria would be able to present antigens to T cells and induce their polarization 
[202]. Our data is supported by another study where inactivated Lactobacillus 
species [169] were shown to modulate the expression of surface maturation markers 
and cytokine production in murine DCs. In addition, another report showed that DC 
maturation markers, especially CD86 and HLA class II were upregulated in human 
DCs in response to live and irradiated bacteria belonging to Lactobacillus, 
Bifidobacterium, and Streptococcus species [203]. 
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5.2 Cytokine responses in human primary cells 
 
Both DCs and macrophages produce cytokines and chemokines in response to 
microbial stimulation. However, the amount and repertoire of cytokines differ 
depending on the cell type and bacterial strain and dose used to stimulate the cells. 
 
5.2.1 Comparison of DC and macrophage cytokine responses (I, II) 
 
The mammalian immune system has the ability to launch distinct types of immune 
responses against different microbes. In addition to the upregulation of 
costimulatory molecules, the maturation process of DCs includes the secretion of 
cytokines and chemokines in response to antigen stimulation or microbial infection. 
When this study was commenced, there were no reports on the effects of the studied 
bacteria, other than LGG, on human DCs. Previously, the cytokine profiles 
generated by exposure to these bacteria [204] and to another set of multiple non-
pathogenic bacteria [205] were analysed in human PBMCs. To our knowledge, we 
were the first ones to screen the cytokine profiles and inflammatory responses 
induced by multiple probiotic or potentially probiotic bacteria in the human DC 
model system. 
 
In addition to maturation markers (Fig. 3 in I), some non-pathogenic bacteria were 
able to stimulate cytokine and chemokine production in DCs (Fig. 1-2 in I). 
Previously, the ability of LGG to stimulate cytokine and chemokine production in 
human DCs [200] and macrophages [113, 206] had been analysed, but other non-
pathogenic bacteria were not included in these studies. In our studies DCs showed 
more versatile cytokine profiles to different bacteria than macrophages (Fig. 1 in I 
and Fig. 5). In agreement with the previous study by Veckman and coworkers [200], 
LGG was quite inert in inducing cytokines in human DCs. This was also the case 
with another Lactobacillus rhamnosus strain LC705, while for example 
Bifidobacterium strains Bb12 and Bb99 efficiently induced production of all the 
measured cytokines (TNF-α, IL-1β, IL-6, IL-10, IL-12, and IFN-γ). Streptococcus 
thermophilus THS on the other hand induced proinflammatory cytokines TNF-α, 
IL-6, and IL-12 but no IL-1β or anti-inflammatory IL-10. We concluded that 
although DC maturation marker expression is similarly induced in response to 
bacteria representing different genera, the cytokine production profiles can vary 
greatly between the bacteria. It might be that these bacteria induce different stages of 
DC maturation. DCs expressing moderate levels of costimulatory molecules but 
having restricted ability to induce cytokine responses are considered as semi-mature 
DCs [19, 200] that may be involved in the induction of regulatory T cells [207]. 
Thus, in our DC model system at least LGG and LC705 could support the 
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generation of regulatory T cells as suggested by their increased maturation marker 
expression [200] and low capacity to stimulate cytokine production (Fig. 1 in I). 
 
 
 
 
Figure 7.  Production of proinflammatory cytokines IL-1β , IL-6, and TNF-α  in 
macrophages stimulated with different bacteria. Macrophages were 
stimulated with different doses of bacteria (bacteria:macrophage ratios of 
2:1, 10:1, and 50:1) for 24 h and the cytokine levels were analysed from 
cell culture supernatants by ELISA. Macrophages seem to respond 
strongly to bacterial stimulation and produce large amounts of 
proinflammatory cytokines. GAS, Streptococcus pyogenes; LGG, 
Lactobacillus rhamnosus GG; LC705, Lactobacillus rhamnosus LC705; 
THS, Streptococcus thermophilus THS; ARH74, Lactococcus lactis subsp. 
cremoris; PIA2, Leuconostoc mesenteroides subsp. cremoris PIA2; 1129, 
Lactobacillus helveticus 1129; 161, Lactobacillus helveticus Lb161; PJS, 
Propionibacterium freudenreichii subsp. shermanii JS; Bb12, 
Bifidobacterium animalis subsp. lactis Bb12; Bb99, Bifidobacterium breve 
Bb99; 1/10, Bifidobacterium longum 1/10. 
 
Bifidobacterium strains Bb12 and Bb99 induced production of all the measured 
cytokines, including anti-inflammatory IL-10 in DCs (Fig. 1 in I). The ability of 
bifidobacteria or their secreted compounds to induce IL-10 has been characterized  
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before in in vitro cell models and clinical trials [168, 187, 205]. Since IL-10 has the 
ability to suppress proinflammatory cytokine production it might be one factor 
contributing to the observed immunomodulatory effects of bifidobacteria [208]. IL-
10 is generally accepted to be involved in the generation of regulatory T cells [15]. 
In addition to IL-10 production in DCs, we observed the ability of bifidobacteria to 
induce IL-10 production in human macrophages (Fig. 1 in II), suggesting that both 
cell types participate in the regulation of inflammatory responses via IL-10 
production. 
 
The production of proinflammatory TNF-α and IL-6 was induced efficiently by all 
bacteria in macrophages and the levels were higher compared with the cytokine 
levels in bacteria-stimulated DCs (Fig. 1 in I and Fig. 7). Previously the ability of 
LGG to induce TNF-α and IL-6 in macrophages was analysed [113] and these 
results are in line with the ones presented now. However, LGG and LC705 were 
unable to induce TNF-α production in DCs. TNF-α is known to promote 
inflammatory responses by upregulating many inflammatory molecules including 
other cytokines [209]. Our results indicate that macrophages respond with a strong 
proinflammatory cytokine pattern to all bacteria, while DCs are more selective. Thus, 
these two cell types probably have distinct roles in the initiation of immune 
responses against microbes. This supports the role of macrophages in being an 
important cell type regulating inflammatory responses in tissues. The importance of 
macrophages in the early control of infections has been previously characterized 
[210]. 
 
The production of IL-1β is used as an indicator of inflammasome activation. In 
contrast to macrophages that induced high levels of IL-1β in response to bacterial 
stimulation (Fig. 7), in DCs only four non-pathogenic bacterial strains were able to 
induced inflammasome activation (Fig. 1 in I). IL-1β was efficiently induced in DCs 
after stimulation with Bifidobacterium strains Bb12 and Bb99 as well as with 
Lactococcus lactis ARH74 and Lactobacillus helveticus 1129 while other strains 
were unable to stimulate IL-1β production. It is interesting that the pathogenic GAS 
could not induce IL-1β production and inflammasome activation in DCs but induced 
it efficiently in macrophages. The data suggests that the inflammasome complex is 
activated in macrophages in response to all kinds of bacterial stimulation while only 
a few bacteria are able to activate the inflammasome complex in DCs, thus caspase-
1 activation and cleavage of pro-IL-1β into its active secreted form.  
 
Our data shows that DCs produce differential patterns of cytokines in response to 
various bacterial strains. Macrophages on the other hand respond more strongly to 
bacterial stimulation with less dramatic differences between bacteria. (Fig. 1 in I, 
Fig. 1 in II, and Fig. 7). Thus, the immunomodulatory effects of probiotic bacteria 
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may be due to their ability to stimulate the production of cytokines in immune cells 
such as macrophages and DCs. These stimulatory properties are likely to differ 
between bacteria since different bacterial strains possess diverse MAMPs, secreted 
bacterial proteins, or other metabolites as previously shown [183, 185-187, 211]. 
Most of the studies show the favorable effects of bacterial soluble proteins on 
intestinal epithelial cell growth and survival. However, in human macrophages [212] 
and murine DCs [169] also inactivated Lactobacillus strains were able to stimulate 
cytokine production. These data suggest that no active metabolism or secreted 
bacterial components are required for human macrophage or murine DC cytokine 
responses to these Lactobacillus strains. Thus, the inflammatory responses and 
cytokine profiles induced by different bacteria are likely due to interactions of 
bacterial surface components with their cognate receptors and only in some cases 
secreted bacterial metabolites are needed to mediate the inflammatory responses. 
 
5.2.2 Comparison of the cytokine production profiles of  
non-pathogenic and pathogenic bacteria (I, II) 
 
Compared with pathogenic GAS, some non-pathogenic bacteria induced cytokine 
production more efficiently in DCs (Fig. 1 in I). For example proinflammatory IL-
1β was practically not detected from GAS-stimulated DCs, while some of the non-
pathogenic bacterial strains belonging to Bifidobacterium, Lactobacillus, or 
Lactococcus genera efficiently induced IL-1β production. The inability of this GAS 
strain to induce IL-1β secretion might be a mechanism of pathogenesis and a 
concequence of the actions of bacterial virulence factors. However, GAS-
stimulation induced DC maturation and the production of proinflammatory 
cytokines such as TNF-α, IL-6, IL-12, and IFN-γ. This suggests that although the 
inflammasome complex is not activated in DCs after GAS stimulation, the 
bacterium is able to trigger other proinflammatory responses. It is interesting that 
there were also non-pathogenic bacteria such as the two Lactobacillus strains LGG 
and LC705, Streptococcus thermophilus THS, Leuconostoc mesenteroides PIA2, and 
Bifidobacterium longum 1/10, which were unable to induce IL-1β production. The 
non-pathogenic Streptococcus thermophilus THS induced mainly proinflammatory 
cytokines TNF-α, IL-6, and IL-12 in DCs, showing a similar trend with GAS in its 
ability to induce cytokine production in DCs. However, the cytokine levels were 
higher than in GAS-stimulated DCs. Thus, both the pathogenic GAS and some non-
pathogenic bacteria belonging to different genera were unable to activate the 
inflammasome in DCs. This suggests that the inability to activate the inflammasome 
is not always related to the pathogenicity of the bacterium. The bacterial factors and 
mechanisms behind these phenomena remain unknown and they likely differ 
between bacterial strains. This would be an interesting topic for further research. 
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The production of IL-10 in DCs after bacterial stimulation had a similar trend as IL-
1β production. Thus, the same bacteria were able or unable to iduce IL-1β and IL-10 
production (Fig 1 in I). IL-10 suppresses the production of proinflammatory 
cytokines especially IL-12 [101, 102]. The strong proinflammatory responses in 
GAS infections could be related to the lack of IL-10 production and its suppressive 
effects on proinflammatory responses. The non-pathogenic bacteria which were 
unable to induce IL-10 production (Lactobacillus strains LGG and LC705, 
Streptococcus thermophilus THS, Leuconostoc mesenteroides PIA2 and one 
Bifidobacterium strain 1/10) were also poor inducers of proinflammatory TNF-α, 
IL-1β, IL-12, and IFN-γ, except for Streptococcus thermophilus THS which strongly 
induced TNF-α, IL-6, and IL-12 production. It is interesting that the non-pathogenic 
Streptococcus strain induced more efficient inflammatory responses than pathogenic 
GAS in DCs. 
 
In macrophages the differences in proinflammatory cytokine levels between the 
studied bacteria were not that clear, and all bacteria were able to induce production 
of the measured proinflammatory cytokines IL-1β, IL-6 and TNF-α (Fig. 7). 
However, some differences were seen in IL-12 and IL-10 production levels (Fig 1 in 
II). This data highlights the strain-specific effects of different bacteria which have 
also been characterized in other studies [169, 203, 205, 213]. Thus, based on our 
studies and those by others, the immune responses induced by bacteria must be 
characterized individually for each bacterial strain. 
 
5.2.3 The anti-inflammatory potential of bacteria - IL-10/IL-12 ratio (II) 
 
It is widely accepted that the gut microbiota has an immunomodulatory capacity and 
play an important role in the health of the host. It has been suggested that the 
balance between Th1 and Th2 immunity as well as immune tolerance may be 
controlled by DCs [214, 215]. The capacity of bacterial strains to induce different 
cytokine profiles suggests that bacteria may differentially determine DC polarization 
patterns. Thus, bacteria can be classified as anti-inflammatory Th2 -type or 
inflammatory Th1 -type strains based on their ability to stimulate cytokine 
production. IL-12 is an important cytokine in inducing Th1 responses by eliciting 
IFN-γ production by T cells and NK cells [216]. Anti-inflammatory IL-10 favors 
Th2 or Treg responses via suppression of IL-12 production [217]. Since, IL-10 has 
the ability to downregulate the production of IL-12 [205, 218, 219], the IL-10/IL-12 
ratio can be used as an indicator for the immunomodulatory potential of a bacterium 
[168, 220]. There are reports showing that probiotic bacteria are able to modulate 
the Th1/Th2 balance towards Th1, which may downregulate overactive Th2-
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mediated allergic responses [221, 222]. On the contrary in Th1-mediated 
autoimmune conditions such as IBS, probiotic treatment can balance the Th1/Th2 
ratio towards Th2 responses [208].  
 
In DCs and macrophages some bacteria can induce the production of anti-
inflammatory IL-10 while others induce modest or undetectable levels of IL-10 (Fig. 
1 in I, Fig. 1 in II). Also great differences in IL-12 production between the studied 
bacteria were seen. The most potent IL-10 inducers were not the same bacterial 
species in both cell types. For example LGG induced IL-10 production in 
macrophages but not in DCs, THS in turn induced both IL-10 and IL-12 in 
macrophages but only IL-12 in DCs. Although, the effects of probiotic bacteria seem 
to be strain specific, previous studies show that many Bifidobacterium strains are 
potent inducers of IL-10 [168, 204, 223]. In our studies bifidobacteria were efficient 
inducers of IL-10 in macrophages and DCs, which might explain their anti-
inflammatory effects in clinical trials [208]. 
 
Macrophages are often divided into classically or alternatively activated 
macrophages based on their IL-10/IL-12 production ratio [224, 225]. Classically 
activated macrophages are an important source of IL-12 [219], while alternatively 
activated macrophages produce higher levels of IL-10 and reduced levels of IL-12. 
As shown in our studies with macrophages, bifidobacteria have high anti-
inflammatory potential (Fig. 2 in II). Many clinical studies also suggest that LGG 
has immunomodulatory potential [144, 145, 149, 150, 204, 226]. This is supported 
by our results showing that Lactobacillus rhamnosus strains LGG and LC705 have 
relatively high anti-inflammatory potential in human macrophages. 
 
Excessive production of Th1 cytokines can contribute to tissue destruction and 
development of autoimmune diseases such as multiple sclerosis, diabetes, and 
systemic lupus erythematosus (SLE). However, Th1 cytokines may be protective 
against Th2-related chronic inflammatory conditions including asthma and atopy. It 
has been proposed that probiotic-induced low-grade inflammation could protect 
from atopic eczema [222]. Gastrointestinal disorders such as Crohn’s disease are 
linked to the predominance of Th1 cytokines while ulcerative colitis is associated 
with production of Th2 cytokines such as IL-5. It would be desirable to modulate the 
unwanted immune responses in these conditions with administration of probiotic 
strains which are able to modulate the Th1/Th2 cytokine balance of the host. Based 
on our results, the two Bifidobacterium strains Bb12 and Bb99 and L. helveticus 
1129 are probably the most potent inducers of anti-inflammatory responses, based 
on their ability to induce IL-10 production in both cell types and their IL-10/IL-12 
ratio in macrophages (Figure I in I, Figs. 1 and 2 in II). The Bifidobacterium strain 
Bb12 is widely used in dairy products in Europe, extensively studied, and previously 
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shown to limit the duration of diarrhea [227-229]. Bb99 has been used in a probiotic 
mixture which was able to alleviate the symptoms of IBS [152, 153]. L. helveticus 
1129 has been previously studied only in vitro [204, 230] and no clinical evidence of 
its immunomodulatory effects is available. Thus, it would be an interesting 
bacterium for further research. 
 
The immunomodulatory properties of a particular bacterium can vary with different 
bacterial doses [223]. IL-10 is induced more efficiently with a high bacterial dose 
[169] suggesting that the optimal bacterial dose for each cytokine must be 
individually determined. The anti-inflammatory potential of a bacterium is most 
likely a result of complicated interactions with epithelial cells, immune cells, and 
commensal microbes combined with the cytokine milieu in different tissues. These 
in vitro results of the present studies give some guidance how to select the potential 
anti-inflammatory bacterial strains, and point out possible new bacterial strains that 
have not yet a probiotic status for clinical trials. 
 
5.2.4 Probiotic-induced SOCS3 expression and regulation of cytokine 
responses (II) 
 
SOCS proteins, the negative regulators of cytokine signalling, are inducible upon 
cytokine stimulation and implement their regulatory properties by interfering with 
the JAK/STAT pathway [131]. The expression of SOCS3 is known to be regulated 
by both anti-inflammatory IL-10 and proinflammatory cytokines to control cytokine 
expression [134, 231, 232]. 
 
In our studies with DCs, non-pathogenic bacteria, especially the Bifidobacterium 
strains, were able to induce IL-10 production more efficiently than other bacteria.  
This directed our interest to the regulatory mechanism behind the proposed anti-
inflammatory effects of bifidobacteria and the role of IL-10 production in these 
events. At the time we started to study the role of SOCS3 in the immune responses 
induced by probiotic and other non-pathogenic bacteria, to our knowledge, no 
publications were available on the role of SOCS3 in human immune cell responses 
to probiotic stimulation. During our studies, the role of SOCS3 in bifidobacteria-
stimulated mouse macrophage cell line [233], and later on a report about the 
probiotic actions mediated by SOCS3 during Helicobacter pylori infection in a 
human gastric carcinoma cell line were published [234]. 
 
Non-pathogenic bacteria were able to induce SOCS3 gene expression in 
macrophages (Fig. 3 in II). As known from previous studies [231, 235], SOCS3 is 
upregulated by IL-10, and as expected, the ability of a bacterium to induce IL-10 
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correlated with SOCS3 expression levels in our macrophage model as well. The 
SOCS3 gene expression was induced by bacteria at 8 h after stimulation in the 
absence of protein synthesis (Fig. 4 in II). Thus, SOCS3 mRNA expression is a 
direct consequence of bacteria-macrophage interaction. SOCS3 mRNA expression 
increased up to 24 h after stimulation suggesting that a positive feedback loop might 
exist (Fig. 3 in II). Since neutralising IL-10 antibodies were able to decrease 
bacteria-induced SOCS3 mRNA expression we concluded that SOCS3 expression is 
enhanced also indirectly via bacteria-induced IL-10 production (Fig. 6 in II). The 
immunoregulatory effects of LGG seen in clinical studies as decreased production of 
IL-6 and TNF-α in healthy individuals [226] and reduction in TNF-α production in 
allergic children [150] may partly be regulated by SOCS3. Our data shows that 
LGG-stimulation upregulates SOCS3 mRNA expression (Fig. 3 in II). Since LGG 
activates STAT1 and STAT3 DNA binding [113] and STAT3 is known to be 
involved in IL-10 induced SOCS3 expression in human macrophages [236] it is 
likely that SOCS3 is a negative regulator of probiotic-induced cytokine responses 
via IL-10 production and inhibition of the JAK/STAT pathway (Figure 5). 
 
Genes of many proinflammatory cytokines such as IL-1β, TNF-α, and IL-12 are 
regulated by NF-κB. It was previously shown that bifidobacteria decreased LPS-
induced inhibitor of NF-κB (IκB)-α phosphorylation in a macrophage cell line [233], 
which is probably one factor contributing to their anti-inflammatory effects. 
Additionally, lactobacilli were shown to have similar effects [234, 237]. Thus, the 
anti-inflammatory effects seen in clinical trials, animal studies, and cell cultures in 
response to probiotic bacteria are most likely due to a combination of different 
regulatory mechanisms. These involve the suppression of proinflammatory cytokine 
production by inhibiting NF-κB activation and induction of inhibitory molecules 
such as SOCS to further downregulate the signalling cascades involved in these 
inflammatory responses. Modifying the SOCS3 pathway could offer a new 
therapeutic approach to the management of some autoimmune diseases such as IBD. 
 
5.2.5 Contribution of streptococcal viability and bacterial virulence 
factors to innate immune responses (III) 
 
There are conflicting reports on the role of bacterial viability in the immune 
responses they induce in vitro. The impaired ability of heat-inactivated GAS to 
induce cytokine production in human DCs was previously characterized [200]. 
However, also opposing data in support of similar immunostimulatory potential of 
live and dead bacteria exist on human macrophages [212]. Our data from 
macrophages stimulated with live and inactivated GAS (Fig 1 in III) showing similar 
cytokine responses at later time point of infection, suggests that GAS does not 
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secrete metabolites that induce or inhibit inflammatory responses in macrophages 
and DCs. Heat-inactivated bacteria induced lower cytokine mRNA levels in 
macrophages than live GAS at early time points of stimulation, but the cytokine 
levels were comparable to live bacteria at later time points (Figs. 1, 2, and 3 in III). 
We conclude that heat-inactivation of bacteria might modulate bacterial surface 
molecules and result in differential recognition by immune cells compared with 
viable bacteria, thus leading to differences in the kinetics of cytokine mRNA 
expression. This data shows that bacterial viability does not contribute to final 
outcome of the immune responses induced in human macrophages by GAS 
stimulation (Fig. 1 in III). 
 
Streptococcal virulence factors, streptolysins, have a role in GAS pathogenicity and 
increased streptolysin O (SLO) expression has been detected in GAS strains isolated 
from invasive infections [173]. SLO is a cholesterol-dependent cytolysin that 
participates in the formation of transport vesicles and their fusion with endosomes. It 
is shown to block clathrin-dependent pathway for internalization of GAS in human 
keratinocytes and it is involved in the inhibition of lysosomal degradation of GAS. 
Thus, helping the bacterium to escape into the cytoplasm to avoid lysosomal killing 
[238, 239]. Instead, a mutant bacterium lacking functional SLO was internalized into 
lysosomes in human keratinocytes [239]. SLO can form pores in host cell 
membranes and the gene encoding SLO is co-transcribed with another bacterial 
factor, nicotinamide adenine dinucleotide (NAD+)-glycohydrolase (SPN), which is 
translocated with SLO into the cytoplasm of target cells to deplete the host cell 
energy stores [240]. Streptolysin S (SLS) is unrelated to SLO and other cholesterol-
binding cytolysins and its functions are associated with intracellular invasion of 
GAS [241]. Based on these data, the hypothesis of our study was that GAS with 
impaired ability to produce streptolysins would induce differential immune reponses 
compared with wt GAS in human macrophages. However, streptolysin deficient 
bacteria, SLO- and SLS-, did not induce differential cytokine responses compared 
with wild type GAS in human macrophages (Fig. 1 in III). This suggests that 
streptolysins alone do not contribute to the immune responses induced in human 
macrophages by GAS stimulation. Instead, multiple virulence factors are involved in 
the bacterial pathogenicity of GAS and the outcome of inflammatory responses 
against this bacterium. 
 
A previous report showed that SLO and bacterial viability were essential for 
caspase-1 activation and IL-1β processing in murine macrophages [242]. These 
results are conflicting with our data which show similar IL-1β processing in 
macrophages stimulated with live, inactivated, or streptolysin deficient GAS (Fig. 5 
in III). The differences between these studies are likely due to different host species. 
Of note, mouse is not a natural host for GAS, thus the responses are likely to be 
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different between murine and human cells. Since human macrophages seem to 
respond with a quite similar proinflammatory response also to different non-
pathogenic bacteria (Fig. 5) it might be typical for macrophages to induce a strong 
proinflammatory response to any kind of microbial stimulation. 
 
Activation of the NALP3 inflammasome in macrophages is not dependent on 
streptolysins since wild type GAS as well as virulence factor defective mutants SLO- 
and SLS- induced inflammasome activation equally well (Fig. 5 in III). It has been 
suggested that bacterial toxins such as listeriolysin O (LLO) and streptococcal 
streptolysins SLO and SLS are involved in initiating the second signal for the 
inflammasome activation which leads to caspase-1 activation and maturation of IL-
1β [242]. However, this was not supported by our studies and it is possible that 
some other bacterial or cellular factors in GAS-stimulated macrophages provide the 
second signal for inflammasome activation. Bacteria-induced cell stress may also be 
able to activate the inflammasome. Inflammasome activation requires the 
cooperation of multiple signalling pathways since inhibition of MAPK (ERK, p38, 
JNK), PI3K, or NF-κB pathways with pharmacological inhibitors resulted in 
impaired production of mature IL-1β in GAS-stimulated macrophages (Figs. 7 and 8 
in III). 
 
Type I IFNs play an important role in host protection against bacteria and viruses 
[106, 116]. There are several reports on the ability of different bacteria to induce 
type I IFN production. Intracellular pathogens such as Salmonella Typhimurium, 
Shigella flexneri [106, 243] and L. monocytogenes [106, 244, 245] as well as some 
extracellular streptococci [113, 246, 247] and Lactobacillus species [51, 212] are 
able to induce type I IFN responses. Results from Miettinen et al. [212] show that 
type I IFNs are not induced by all Gram-positive bacteria, since the two 
Lactobacillus strains LGG and LC705 differentially induced type I IFNs. It has been 
shown previously that GAS-encoded cytolysins SLO and SLS were not required for 
IFN responses in murine macrophages [191]. These results are in line with ours, 
showing that IFN production in human macrophages after GAS-stimulation is 
independent of streptolysins. This is interesting since it was shown previously that 
cytolysins or their indirect effects are required for type I IFN production in L. 
monocytogenes infection [210, 248-250]. The Listeria-derived cytolysin LLO, 
which is responsible for the IFN-β responses [249], is functionally related to 
streptococcal SLO. The IFN-β production induced in GAS-stimulated macrophages 
indicates signalling via internalized TLRs or recognition of the bacterium by 
cytoplasmic or endosomal receptors. 
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5.2.6 Role of dynamin-dependent endocytosis in inflammatory 
responses (III) 
 
Dynamin-dependent endocytosis is known to be involved in the internalization of 
particles into cells including different macromolecules, bacteria, and viruses [81-83] 
However, there are endocytic pathways including macropinocytosis which do not 
require dynamin (Figure 4) [251]. Some internalization pathways are constitutively 
active while others are triggered only by specific signals. Blocking the functions of 
dynamin that is involved in pinching of vesicles from the plasma membrane 
attenuates the internalization of many invasive bacteria with active internalization 
mechanisms [243, 252, 253]. GAS is mostly considered as an extracellular 
bacterium without active internalization mechanism and has also the ability to cause 
invasive infections. It is controversial whether GAS can really enter the cells and 
multiply in them. Phagosomal escape and limited survival in non-phagocytic [254-
256] and phagocytic cells [257, 258] have been reported previously. 
 
At the time this study was started, previous studies had shown that GAS could 
induce type I IFN production in mouse macrophages in a partly MyD88-dependent 
manner via activation of IRFs [116, 191]. These reports also showed that in mouse 
macrophages inhibition of dynamin-dependent endocytosis completely abolished 
GAS-induced IFN-β production [116]. Type I IFN production is generally thought 
to result from TLR signalling in endosomal compartments after receptor 
internalization (TLR2 [259], TLR4 [80]) or after endosomal recognition of 
components derived from intracellular bacteria or viruses (TLR3, TLR7, TLR8, 
TLR9). Gratz and coworkers [116] showed that in cells treated with dynasore, a 
dynamin inhibitor, less internalized bacteria were detected at 2 h after stimulation 
but equal amounts in dynasore-treated and -non-treated cells at 3 h after stimulation. 
This suggests that dynasore could slow down the bacterial uptake process. However, 
inhibition of IFN-β mRNA production was seen up to 8 h, indicating that dynasore 
affects the events after bacterial internalization. These studies also showed that the 
ligands that initiate IFN-β production and the signalling molecules involved in these 
responses were cell type-specific and differed in mouse DCs and macrophages. 
Since mouse is not a natural host species of GAS, the responses and signalling 
molecules may be different between mouse and human cells. 
 
Thus, we went on to characterize the role of dynamin-dependent endocytosis in the 
immune responses induced by GAS in human macrophages. We wanted to find out 
whether dynamin-dependent endocytosis is responsible for the GAS-induced IFN-β 
production in human macrophages. Inactivated GAS was included in the studies 
since it was assumed not to be able to deliver GAS-derived components into the host 
cell cytosol. GAS mutants defective in streptolysin genes SLO and SLS were also 
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included, because SLO has been shown to mediate the delivery of GAS-derived 
molecules into the host cytosol and promote bacterial escape from phagosomes into 
the cytosol [239, 260, 260] and SLS is believed to be associated with intracellular 
invasion of GAS [241]. Our studies show that inhibition of dynamin-dependent 
endocytosis in human macrophages by dynasore almost completely blocked 
cytokine mRNA expression, including IL-1β, TNF-α, IFN-β, and CXCL-10 (Figs. 2 
and 3 in III). These results suggest that functional dynamin is required for the 
activation of signalling cascades that lead to cytokine gene expression after GAS-
stimulation. It is well known that signalling from the cell surface TLRs leads to the 
activation of NF-κB and MAPK pathways resulting in the production of 
proinflammatory cytokines, such as TNF-α and IL-1β. Endosomal TLRs in turn 
trigger both IRF-mediated IFN-β and NF-κB-mediated cytokine gene expression. 
TLR2 and TLR4 internalization after ligand binding are dynamin-dependent events 
[53, 80], which is likely to explain at least partly the disturbed IFN-β expression by 
dynasore treatment. Brandt et al. [53] have also suggested that TLR2-dependent NF-
κB activation requires receptor internalization in human monocytes. They used TLR 
ligands in the experiments, and the responses induced by whole bacteria may differ 
from those induced by ligands. Nevertheless, Gratz et al. [191] excluded the 
involvement of TLR2, 4, and 9, and later on the role of TLR3 and 7 [116] in GAS-
induced IFN-β responses in mice and suggested that a new cytoplasmic MyD88-
dependent receptor is involved. However, the putative novel molecule has remained 
uncharacterized. 
 
Since, proinflammatory cytokines TNF-α and IL-1β were blocked by dynasore 
treatment (Fig. 2 in III) it seems that also signalling from the cell surface and the 
activation of the inflammasome complex are inhibited. It was previously shown that 
some inflammatory responses including cytokine production do not necessarily 
require internalization of the target [77-80, 261]. However, also publications 
supporting receptor internalization exist [53, 259]. The inconsistencies between 
these studies may be due to different methods used. The use of mouse macrophages 
and DCs, cell lines, and different stimulants such as microbial components, whole 
bacteria, and viruses are likely to contribute to the results. It remains unclear 
whether receptor internalization is required for signalling. 
 
Dynamin is involved in the internalization of cytokine receptor chains and inhibition 
of these pathways decreased STAT translocation into the nucleus [83, 84]. Thus, 
dynasore treatment may interfere with cytokine networks and their positive and 
negative feedback loops. Sendai virus which is able to directly fuse with the plasma 
membrane [179] and primarily does not use dynamin-dependent mechanisms for 
internalization efficiently induced IFN-β expression that was affected by dynasore to 
a lesser extent (Fig. S2 in III). Interferon-inducible CXCL10 was also induced by 
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Sendai virus, but its expression was in contrast to IFN-β attenuated by dynasore. 
Thus, at least IFN-β mRNA expression and secretion induced by intracellular 
ligands were not completely inhibited by dynasore, since IFN-inducible effects were 
seen. Based on this data, it could be hypothesized that dynasore is able to interfere 
with dynamin-dependent signal transduction from the cell surface, resulting in 
impaired cytokine responses but unable to interfere with IFN-β expression induced 
by intracellular ligands. Dynamin is also involved in actin dynamics and inhibition 
by dynasore possibly interferes with vesicle formation and protein transport inside 
the cells [262, 263]. Data concerning the involvement of dynamin in different 
cellular events is contradictory, since some of these studies are done in yeast instead 
of mammalian cells and the effects may be quite different between non-phagocytic 
and phagocytic cells. We conclude that dynamin is required in the induction of 
cytokine mRNA expression in human macrophages in response to GAS-stimulation. 
However, the exact mechanism remains unexplained. 
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6 Concluding remarks 
In recent years, the knowledge of the interactions between bacteria and their hosts 
has emerged considerably. There is a growing interest towards the health promoting 
properties of probiotic bacteria in the developed world with an increasing incidence 
in asthma and allergy-related diseases. Conclusive evidence is still lacking on the 
mechanisms of probiotic actions because a wide range of different doses and 
bacterial strains are used in various animal and cell models in probiotic studies. The 
mechanisms behind the observed clinical effects of probiotic bacteria as well as the 
mechanisms of bacterial infections remain largely unexplained and the pathogenic 
group A streptococcus, GAS, is among the ten most common causes of death from 
infectious diseases despite effective antibiotic treatment. 
 
The initial aim of the present study was to analyse the ability of potentially probiotic 
bacterial strains to induce cytokine responses in comparison to each other and to the 
pathogenic bacterium GAS in order to facilitate the selection of new bacteria to 
probiotic clinical trials. Pathogenic GAS was analysed to reveal the contribution of 
streptococcal virulence factors, streptolysins, in the pathogenicity of the bacterium 
and the role of dynamin-dependent endocytosis in these responses.  
 
Human monocyte-derived macrophages and DCs were used in these studies, since in 
addition to epithelial cells they are likely to interact with commensal, pathogenic, 
and probiotic bacteria in vivo. Various bacterial strains exhibited different capacities 
to induce innate cytokine responses in human macrophages and DCs. Macrophages 
responded quite similarly to non-pathogenic and pathogenic bacteria with strong 
proinflammatory cytokine responses. Most of the bacteria were also potent inducers 
of anti-inflammatory IL-10 in macrophages. We found that non-pathogenic bacteria 
were able to induce DC maturation as efficiently as the pathogenic GAS. Cytokine 
production in DCs showed more variation between analysed bacteria, indicating a 
more selective role of DCs in initiating immune responses towards non-pathogenic 
and pathogenic bacteria. The main findings were that non-pathogenic bacteria were 
able to induce DC maturation and cytokine production in both cell types, some even 
more efficiently than pathogenic GAS. 
 
The other main focus of this work was to clarify the significance of bacterial 
viability and the role of streptococcal virulence factors in immune responses. We 
found that there were no significant differences in the ability of live, inactivated or 
streptolysin deficient bacteria to induce cytokine responses. Thus, secreted bacterial 
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components are probably not the major regulators of cytokine responses. Cytokine 
responses are obviously regulated by multiple intracellular signalling pathways in 
macrophages and DCs with SOCS3 playing a role at least in IL-10 mediated 
immune responses in macrophages. We also found out that dynamin-dependent 
mechanisms were involved in bacteria-induced inflammatory responses. It is likely 
that these responses result from the cooperation of multiple receptors and receptor 
complexes activated at the cell surface as well as intracellularly. This leads to the 
activation of MAPK, NF-κB, PI3K, and IRF pathways which in case of disturbance 
in one pathway most likely compensate each other in order to maintain the capacity 
to initiate appropriate innate immune responses. 
 
Results of these studies emphasize the complex interactions between microbes and 
host cells and inspire to continue research to reveal the molecular mechanisms 
involved in biological actions of probiotic bacteria. It is also important to understand 
the complexity and mechanisms of the immune responses induced by pathogenic 
microbes in order to control tissue destruction associated with inflammatory 
responses induced by pathogenic bacteria. This information may be useful in further 
development of novel therapeutic strategies against infectious diseases for example 
by modulating the magnitude and quality of cytokine responses. In addition, the 
cytokine production profiles induced by non-pathogenic bacteria could help in 
selecting new potential probiotic bacteria for further studies and for clinical use. 
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